Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository with detailed results at https://github.com/lhncbc/CRI/tree/master/regCTG


Study Counts

Type Study_count
Total_Studies 2617
interventional 2291
Observational 300
Registry 26

Studies over Time

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 1310
Drug|placebo 143
Drug|Radiation 118
Biological|Drug 107
Biological 82
Radiation 75
Drug|Other 59
Procedure 48
Drug|Procedure 43
Other 35
Biological|Drug|Other 21
Device 18
Drug|Procedure|Radiation 18
Behavioral 13
Biological|Drug|placebo 13
Biological|Drug|Radiation 11
Biological|Other 11
Diagnostic Test 10
Drug|Other|placebo 9
Drug|Other|Procedure 9
Drug|Other|Radiation 8
Drug|placebo|Radiation 8
Other|Procedure 8
Procedure|Radiation 8
Biological|placebo 7
Device|Drug 7
Biological|Radiation 6
Other|Radiation 6
Combination Product 5
Other|Procedure|Radiation 5
Dietary Supplement 4
Behavioral|Other|Procedure 3
Biological|Other|Radiation 3
Diagnostic Test|Drug 3
Drug|Genetic|Other 3
Drug|Other|Procedure|Radiation 3
Genetic 3
Behavioral|Drug|placebo 2
Biological|Dietary Supplement|Drug 2
Biological|Drug|Other|placebo 2
Biological|Drug|Other|Radiation 2
Biological|Other|Procedure|Radiation 2
Device|Drug|Radiation 2
Device|Other 2
Dietary Supplement|Drug 2
Drug|Genetic|Other|Procedure 2
Behavioral|Drug|Other|placebo 1
Behavioral|Drug|Other|Procedure 1
Behavioral|Radiation 1
Biological|Combination Product|Drug|Other 1
Biological|Device 1
Biological|Device|Drug|Radiation 1
Biological|Diagnostic Test 1
Biological|Drug|Genetic|Other 1
Biological|Drug|Other|Procedure 1
Biological|Drug|placebo|Radiation 1
Biological|Drug|Procedure 1
Biological|placebo|Radiation 1
Biological|Procedure 1
Combination Product|Drug 1
Combination Product|Other 1
Device|Drug|Other 1
Device|Drug|Other|Procedure 1
Device|Drug|Procedure|Radiation 1
Device|Other|Radiation 1
Device|Procedure 1
Device|Radiation 1
Diagnostic Test|Drug|Other 1
Diagnostic Test|Other|Procedure 1
Dietary Supplement|Drug|Radiation 1
Dietary Supplement|placebo 1
Drug|Genetic 1
Drug|Genetic|Other|placebo 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Genetic|Procedure 1
Drug|Other|placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Intervention_type intervention Study_count Date of First Study
Drug carboplatin 355 2010
Drug paclitaxel 244 2010
Drug cisplatin 233 2014
Drug pemetrexed 210 2014
Drug docetaxel 192 2014
placebo placebo 158 2010
Drug gemcitabine 137 2014
Drug pembrolizumab 133 2015
Drug erlotinib 114 2011
Radiation radiotherapy 105 2016
Other laboratory biomarker analysis 102 2014
Drug bevacizumab 98 2017
Drug nivolumab 91 2015
Drug gefitinib 66 2011
Drug durvalumab 54 2018
Drug cetuximab 48 2009
Drug gemcitabine hydrochloride 44 2017
Drug vinorelbine 40 2010
Drug osimertinib 36 2018
Drug atezolizumab 35 2016
Drug erlotinib hydrochloride 34 2017
Drug chemotherapy 33 2017
Biological ipilimumab 33 2014
Drug nab-paclitaxel 31 2014
Other quality-of-life assessment 31 2014
Other pharmacological study 29 2013
Drug pemetrexed disodium 26 2017
Radiation stereotactic body radiation therapy 24 2010
Drug afatinib 21 2013
Drug etoposide 20 2014
Other questionnaire administration 20 2014
Drug crizotinib 19 2016
Drug erlotinib [tarceva] 19 2010
Drug anlotinib 16 2018
Drug ramucirumab 16 2010
Drug celecoxib 15 2007
Radiation radiation 14 2018
Radiation sbrt 14 2018
Procedure surgery 14 2009
Procedure therapeutic conventional surgery 14 2018
Drug tremelimumab 14 2018
Drug vinorelbine tartrate 14 2011
Drug alectinib 13 2016
Drug avelumab 13 2017
Procedure conventional surgery 13 2018
Drug bortezomib 12 2008
Drug icotinib 12 2017
Drug necitumumab 12 2019
Drug selumetinib 12 2018
Drug sintilimab 12 2018
Drug brigatinib 11 2018
Drug cyclophosphamide 11 2009
Drug vorinostat 11 2009
Other best supportive care 10 2011
Drug bibw 2992 10 2009
Radiation 3-dimensional conformal radiation therapy 9 2014
Drug azd9291 9 2016
Drug bevacizumab [avastin] 9 2009
Drug olaparib 9 2016
Radiation stereotactic body radiation therapy (sbrt) 9 2018
Drug sunitinib 9 2008
Drug trametinib 9 2017
Drug pazopanib 8 2009
Drug pemetrexed/cisplatin 8 2010
Drug sorafenib 8 2009
Procedure adjuvant therapy 7 2006
Drug azd6244 7 2010
Drug ceritinib 7 2015
Other ct-scan 7 2009
Drug everolimus 7 2016
Drug gemcitabine/carboplatin 7 2010
Radiation intensity-modulated radiation therapy 7 2014
Drug kg 7 2019
Drug m^2 7 2016
Procedure neoadjuvant therapy 7 2019
Drug oxaliplatin 7 2019
Drug atezolizumab (mpdl3280a), an engineered anti-pd-l1 antibody 6 2017
Drug bibf 1120 6 2011
Drug cabozantinib 6 2018
Drug cediranib maleate 6 2010
Drug concurrent chemotherapy 6 2019
Drug dexamethasone 6 2010
Drug entinostat 6 2016
Drug gemcitabine/cisplatin 6 2010
Other immunohistochemistry staining method 6 2008
Drug irinotecan hydrochloride 6 2007
Drug ldk378 6 2014
Drug medi4736 6 2014
Drug nintedanib 6 2014
Other pet 6 2005
Procedure positron emission tomography 6 2014
Drug standard care 6 2019
Drug veliparib 6 2016
Drug abemaciclib 5 2015
Drug anamorelin hcl 5 2018
Drug anlotinib hydrochloride 5 2019
Drug apatinib 5 2017
Drug arq 197 5 2012
Drug auy922 5 2013
Drug bavituximab 5 2010
Drug canakinumab 5 2019
Drug cobimetinib 5 2018
Other educational intervention 5 2012
Drug erlotinib hcl 5 2009
Genetic gene expression analysis 5 2007
Radiation hypofractionated radiation therapy 5 2014
Drug inc280 5 2014
Drug irinotecan 5 2009
Drug lenvatinib 5 2019
Drug lorlatinib 5 2018
Drug m2 5 2012
Drug mk-3475 5 2014
Drug oleclumab 5 2016
Drug paclitaxel / carboplatin 5 2010
Drug palbociclib 5 2017
Biological pembrolizumab 200 mg 5 2019
Drug pf-00299804 5 2010
Genetic protein expression analysis 5 2007
Radiation split-course radiotherapy 5 2019
Drug temozolomide 5 2000
Radiation thoracic radiotherapy 5 2020
Biological trastuzumab 5 2017
Drug vandetanib 5 2014
Drug ac0010 4 2016
Drug alimta 4 2007
Drug anlotinib/docetaxel 4 2018
Procedure az7550 4 2014
Drug bi 754091 4 2018
Drug binimetinib 4 2019
Drug bkm120 4 2014
Drug cabozantinib s-malate 4 2018
Drug camrelizumab 4 2019
Drug cc-486 4 2014
Biological cixutumumab 4 2010
Other clinical observation 4 2014
Procedure computed tomography 4 2014
Drug dasatinib 4 2016
Drug docetaxel/cisplatin 4 2010
Drug egf816 4 2014
Drug enzastaurin 4 2007
Drug erlotinib (tarceva) 4 2007
Behavioral exercise 4 2017
Drug fludarabine 4 2019
Radiation fludeoxyglucose f 18 4 2009
Dietary Supplement folic acid 4 2010
Drug fruquintinib 4 2015
Drug gemcitabine / carboplatin 4 2015
Drug gemcitabine / cisplatin 4 2015
Drug imatinib mesylate 4 2010
Other immunoenzyme technique 4 2006
Drug mpdl3280a 4 2014
Other observation 4 2020
Drug paclitaxel albumin-stabilized nanoparticle formulation 4 2012
Drug pdr001 4 2016
Drug pemetrexed / carboplatin 4 2015
Drug pemetrexed / cisplatin 4 2015
Drug pemetrexed 500 mg 4 2013
Drug pemetrexed/carboplatin 4 2019
Drug pertuzumab 4 2015
Other pet/ct 4 2018
Drug pf-02341066 4 2007
Procedure pharmacokinetic sampling - az5140 4 2014
Procedure pharmacokinetic sampling - az5140/az7550 4 2014
Procedure pharmacokinetic sampling - azd9291 4 2014
Radiation proton beam radiation therapy 4 2014
Behavioral questionnaire 4 2011
Drug ribociclib 4 2014
Drug s-1 4 2011
Drug single low dose cyclophosphamide 4 2009
Radiation stereotactic body radiotherapy 4 2017
Radiation stereotactic body radiotherapy (sbrt) 4 2019
Drug tak-788 4 2019
Drug tarceva 4 2009
Biological tecemotide (l-blp25) 4 2009
Drug temsirolimus 4 2010
Drug tipifarnib 4 2018
Drug vinorelbine ditartrate 4 2010
Dietary Supplement vitamin b12 4 2010
Drug vitamin c 4 2016
Drug NA 3 2018
Drug 40 mg 3 2018
Drug abi-007 3 2011
Drug alflutinib 3 2018
Drug amifostine trihydrate 3 1999
Drug arq 197/erlotinib 3 2010
Drug axitinib 3 2017
Drug azd3759 3 2017
Drug azd4547 3 2013
Drug azd6738 3 2019
Drug azd9291 80 mg 3 2015
Drug azd9291 tablet dosing 3 2014
Other best available therapy 3 2017
Drug bexarotene 3 2006
Procedure biopsy 3 2018
Other blood sample 3 2018
Drug capecitabine 3 2013
Drug carboplatin/paclitaxel 3 2018
Drug cisplatin 75 mg 3 2013
Drug cisplatin 75 mg/m^2 3 2013
Drug cp-751,871 3 2005
Drug cs-7017 3 2010
Drug dacomitinib 3 2011
Drug danvatirsen 3 2016
Drug darbepoetin alfa 3 2006
Drug durvalumab (medi4736) 3 2019
Procedure ebus-tbna 3 2009
Drug endostar 3 2016
Drug epacadostat 3 2017
Drug exemestane 3 2016
Drug exisulind 3 2004
Radiation fdg-pet 3 2015
Other flow cytometry 3 2006
Drug fludeoxyglucose f-18 3 2018
Drug gefitinib 250 mg 3 2018
Drug gm-csf 3 2013
Radiation image guided radiation therapy 3 2013
Drug ipi 3 2018
Drug itraconazole 3 2015
Drug m7824 3 2018
Other medical chart review 3 2012
Drug metformin 3 2017
Drug metformin hydrochloride 3 2014
Drug mm-121 3 2009
Drug motexafin gadolinium 3 2005
Genetic mutation analysis 3 2010
Drug nimotuzumab 3 2018
Drug paclitaxel 200 mg 3 2013
Drug paclitaxel 200 mg/m^2 3 2013
Drug paclitaxel/carboplatin 3 2010
Drug panitumumab 3 2009
Biological pegfilgrastim 3 2012
Drug pemetrexed 500 mg/m^2 3 2013
Drug placebo/docetaxel 3 2011
Drug platinum 3 2013
Drug porfimer sodium 3 2016
Drug poziotinib 3 2017
Drug rad001 3 2007
Drug saline solution 3 2019
Biological shr-1210 3 2018
Drug sirolimus 3 2012
Drug sitravatinib 3 2019
Drug sorafenib (nexavar, bay43-9006) 3 2009
Radiation stereotactic radiosurgery 3 2016
Radiation stereotactic radiotherapy 3 2009
Drug suramin 3 2012
Drug tcm 3 2011
Drug tepotinib 3 2019
Drug thalidomide 3 2017
Drug tirapazamine 3 2001
Drug topotecan 3 2015
Drug trastuzumab emtansine 3 2014
Drug triapine 3 2004
Drug tyrosine kinase inhibitor 3 2016
Drug vinblastine sulfate 3 2017
Drug zd1839 3 2005
Drug zd6474 3 2003
Drug zoledronic acid 3 2013
Radiation 18 f fluorodeoxyglucose 2 2009
Drug ab928 2 2020
Drug abr-217620 2 2005
Drug abt-751 2 2003
Drug abx-egf 2 2005
Other adjuvant 2 2017
Biological adv 2 2016
Biological adv/hsv-tk 2 2016
Drug afatinib (bibw 2992) 2 2009
Drug afatinib dimaleate 2 2015
Biological ak105 2 2019
Biological aldesleukin 2 2014
Biological alt-803 2 2015
Drug anamorelin hydrochloride 2 2018
Drug anlotinib/pemetrexed 2 2018
Biological antigen-specific dth 2 2019
Drug antroquinonol 2 2014
Drug aprepitant 2 2015
Drug apricoxib 2 2008
Drug apx005m 2 2018
Drug atezolizumab (mpdl3280a) [tecentriq], an engineered anti-pdl1 antibody 2 2015
Biological avastin 2 2014
Drug avastin (bevacizumab) 2 2016
Drug axl1717 2 2011
Drug azacitidine 2 2013
Drug azd4635 2 2016
Drug azd5363 2 2016
Drug azd9150 2 2018
Drug bi 2536 2 2014
Drug bi 754111 2 2018
Drug bms-690514 2 2010
Drug bms-986205 2 2016
Drug bpi-7711 2 2019
Drug capmatinib 2 2019
Drug carboplatin auc6 2 2018
Drug carboplatin) 2 2009
Drug carboplatin/gemcitabine 2 2007
Biological cemiplimab 2 2017
Drug chemo 2 2018
Drug chidamide 2 2018
Biological cik cell 2 2012
Drug cis-platinum 2 2012
Drug cisplatin injection 2 2020
Drug cisplatin/carboplatin 2 2011
Device computed tomography perfusion imaging 2 2017
Biological control dth 2 2019
Other counseling intervention 2 2011
Drug cpt-11 2 2006
Biological cs1001 monoclonal antibody 2 2018
placebo cs1001 placebo 2 2018
Other cytology specimen collection procedure 2 2014
Drug d-0316 2 2019
Drug dabrafenib 2 2011
Drug dacomitinib (pf-00299804) 2 2011
Drug dalotuzumab 2 2008
Drug day 2 2012
Drug decitabine 2 2004
Biological dendritic cell immunotherapy 2 2019
Drug denosumab 2 2014
Drug dexamethasone 4 mg 2 2019
Other diagnostic laboratory biomarker analysis 2 2011
Drug dnib0600a 2 2013
Drug docetaxel (taxotereâ®) 2 2007
Drug docetaxel 75 mg 2 2016
Drug docetaxel/carboplatin 2 2016
Drug docetaxel/pemetrexed 2 2008
Biological dribble vaccine 2 2009
Drug ds-1205c 2 2018
Combination Product durvalumab / monalizumab 2 2018
Combination Product durvalumab / oleclumab 2 2018
Drug ec20 2 2012
Drug ef5 2 2014
Drug egfr 2 2017
Biological enoblituzumab 2 2015
Drug ensartinib 2 2016
Drug entrectinib 2 2015
Drug eribulin mesylate 2 2006
Radiation external beam radiation therapy 2 2012
Device flt-pet 2 2016
Dietary Supplement folic acid 350-1000 î¼g 2 2019
Drug gdc-0941 2 2009
Drug gefitinib (iressa) 2 2009
Drug glumetinib 2 2019
Drug gtx-024 2 2011
Biological hla-a*2402restricted urlc10, cdca1, 2 2013
Drug hm61713 2 2012
Drug hsp90 inhibitor auy922 2 2013
Biological hsv-tk 2 2016
Drug hydroxychloroquine 2 2009
Radiation hypofractionated radiotherapy 2 2009
Drug ibrutinib 2 2014
Drug ifosfamide 2 2005
Device ima_detect 2 2018
Radiation image-guided radiation therapy 2 2018
Drug iressa 2 2005
Biological isis 3521 2 1999
Drug itacitinib 2 2018
Drug ixabepilone 2 2009
Drug ixabepilone, 32 mg 2 2008
Drug jnj-61186372 2 2019
Biological kn046 2 2019
Drug l-dos47 2 2013
Drug lapatinib 2 2011
Drug lazertinib 2 2019
Procedure lobectomy 2 2017
Procedure local consolidation therapy 2 2018
Drug lxh254 2 2017
Drug ly2603618 2 2009
Biological ly2875358 2 2012
Drug ly900003 2 2002
Drug methylprednisolone 2 2013
Drug midazolam 2 2014
Drug mifepristone 2 2015
Drug min 2 2013
Drug minocycline 2 2011
Drug mk-2206 2 2011
Drug ml intravenous solution 2 2019
Combination Product monalizumab 2 2018
Drug nab paclitaxel 2 2020
Procedure needle biopsy 2 2010
Biological neo-pv-01 2 2017
Drug niraparib 2 2017
Drug nivolumab 10 mg 2 2019
Drug nivolumab 10 mg/ml intravenous solution 2 2019
Biological nk immunotherapy 2 2016
Device novottf-100l 2 2008
Drug onartuzumab 2 2013
Drug ono-4538 2 2015
Drug oral vinorelbine 2 2008
Drug osi-906 2 2010
Drug osimertinib mesylate tablets 2 2018
Drug paclitaxel injection 2 2020
Drug patupilone 2 2005
Biological pembrolizumab 2 mg 2 2016
Biological pembrolizumab 2 mg/kg 2 2016
Drug pemetrexed (alimta) 2 2009
Device pet scan imaging 2 2015
Drug pf-06463922 2 2013
Drug pf-3512676 2 2002
Other pharmacogenomic studies 2 2012
Other pharmacokinetic study 2 2018
Drug photodynamic therapy 2 2013
Radiation photon beam radiation therapy 2 2012
Radiation photon therapy 2 2009
Drug pi-88 2 2005
placebo placebo azd9291 80 mg 2 2015
placebo placebo capsule 2 2013
placebo placebo for olaparib 2 2020
placebo placebo gefitinib 250 mg 2 2018
Drug platinum-based chemotherapy 2 2017
Drug plb1001 2 2020
Drug ponatinib 2 2013
Drug pralatrexate 2 2000
Radiation proton radiotherapy 2 2007
Radiation proton therapy 2 2009
Procedure radiofrequency ablation 2 2007
Radiation radiolabeled (99tc) ec-dg (ethylenedicysteine-deoxyglucose) 2 2009
Biological ras peptide cancer vaccine 2 2007
Biological recombinant ephb4-hsa fusion protein 2 2017
Drug recombinant human endostatin 2 2010
Drug regn2810 2 2018
Drug regn2810/chemo/ipi 2 2018
Drug regorafenib 2 2018
Other rehabilitation education 2 2017
Behavioral rehabilitation training 2 2017
Drug retifanlimab 2 2018
Biological romiplostim 2 2019
Radiation sabr 2 2018
placebo saline placebo for pembrolizumab 2 2016
Drug sar408701 2 2019
Drug savolitinib 2 2019
Drug selinexor 2 2017
Drug selpercatinib 2 2020
Drug simvastatin 2 2014
Procedure single photon emission computed tomography 2 2016
Biological sintilimab injection 2 2020
Drug sndx-275 2 2008
Drug sorafenib tosylate 2 2007
Drug spartalizumab 2 2019
Drug standard chemotherapy 2 2013
Procedure standard follow-up care 2 2013
Procedure stereotactic ablative radiotherapy (sabr) 2 2015
Drug sunitinib malate 2 2008
Other supportive care 2 2016
Procedure surgical resection 2 2019
Drug tagrisso 2 2016
Drug talactoferrin 2 2009
Drug tarceva (erlotinib hcl) 2 2004
Drug tarceva (trademark) (erlotinib hcl, osi-774) 2 2004
Drug taxol 2 2005
Drug taxotere 2 2004
Biological tg4010 2 2017
Procedure therapeutic thoracoscopy 2 1999
Radiation thoracic irradiation 2 2020
Radiation thoracic radiation therapy (trt) 2 2018
Procedure thoracic surgical procedure 2 2017
Drug tislelizumab 2 2020
Drug tisotumab vedotin 2 2017
Drug tki 2 2018
Drug tlk286 2 2004
Drug topotecan hydrochloride 2 2006
Biological toripalimab 2 2019
Drug tq-b3139 2 2019
Drug trastuzumab deruxtecan (ds-8201a) 2 2019
Drug valacyclovir 2 2016
Biological vegfr2 2 2009
Drug velcade 2 2006
Drug vemurafenib 2 2017
Drug vidaza 2 2014
Procedure video-assisted surgery 2 1999
Drug vinorelbine (navelbine) 2 2008
Drug vinorelbine/cisplatin 2 2011
Drug vistusertib 2 2017
Dietary Supplement vitamin b12 1000 î¼g 2 2019
Device voc analysis 2 2018
Radiation whole-brain radiotherapy 2 2015
Drug x-396 (ensartinib) 2 2016
Drug xl647 2 2007
Drug ym155 2 2010
Drug zimberelimab 2 2020
Drug [11c]osimertinib 1 2018
Drug [14c]pf00299804 1 2009
Radiation [18f]fluoroglucose(fdg) 1 2015
Drug 01 1 2002
Drug 1 year follow-up; 1 2020
Drug 100 mg 1 2014
Drug 100mg 1 2014
Drug 160 mg 1 2020
Drug 1650-g vaccine 1 2008
Drug 18f-arag 1 2019
Drug 18f-fdg 1 2015
Procedure 18f-fdg-pet scan 1 2014
Drug 18f-fludeoxyglucose (18f-fdg) 1 2013
Drug 18f-fluoromisonidazole 1 2012
Drug 18f-fmiso 1 2013
Drug 18f-fpprgd2 1 2013
Drug 18f-fspg 1 2015
Other 18f-pd-l1 1 2018
Drug 1st line chemotherapy 1 2006
Other 2-deoxy-2-[18f]fluoro-d-glucose (fdg) 1 2007
Radiation 2.5 gy 1 2018
Radiation 2.5 gy/fraction 1 2018
Drug 2503 1 2017
Procedure 2d vats lobectomy 1 2019
Other 3’-deoxy-3’-[18f]fluorothymidine (flt) 1 2007
Radiation 3-d crt) 1 2014
Radiation 3-dimensional conformal radiation therapy (3d-crt) 1 2017
Radiation 34 gy in a single fraction 1 2013
Diagnostic Test 3d-ex 1 2017
Radiation 3d conform radiotherapy 1 2009
Procedure 3d vats lobectomy 1 2019
Diagnostic Test 4-d ct scan 1 2017
Drug 40mg 1 2018
Other 4d-ct scan 1 2012
Device 4d pet-ct 1 2011
Drug 5-flourouracil 1 2018
Drug 5-fluorouracil) 1 2013
Radiation 54gy 18gy 1 2013
Radiation 54gy 18gy/fr. x 3 fractions 1 2013
Drug 6-hydroxymethylacylfulvene 1 1999
Radiation 60 gy rt 1 2007
Radiation 60gy (12 x 5 fr.s) 1 2013
Radiation 60gy (7.5gy x 8fr.) 1 2013
Other 68ga-nota-ae105 pet 1 2016
Other 68ga-nota-ae105 pet/ct 1 2016
Drug 7-hydroxystaurosporine 1 2002
Radiation 70 gy in 20 fractions over 4 weeks 1 2015
Radiation 74 gy rt 1 2007
Diagnostic Test 89zr-avelumab pet 1 2018
Drug 89zr-pembrolizumab 1 2016
Device 89zr-pembrolizumab pet 1 2016
Drug a) standard maintenance programme group, pembrolizumab 200mg, every 3 weeks, for a total of 2 years of follow-up 1 2020
Drug a) standard maintenance programme group, pembrolizumab 200mg, every 3 weeks, for a total of 2 years of follow-up/follow-up for 1 year; 1 2020
Procedure a: radiotherapy alone 1 2005
Drug ab154 1 2020
Drug abbv-181 1 2019
Drug abbv-184 1 2020
Drug abbv-368 1 2019
Drug abbv-927 1 2019
Drug abexinostat 1 2018
Drug abi-007 (abraxane) 1 2006
Drug abi-007 (abraxane)/carboplatin 1 2006
Biological abi-007/carboplatin/trastuzumab 1 1999
Drug abiraterone acetate 1 2016
Drug abp 215 1 2013
Drug abraxane 1 2017
Drug abraxane (induction) 1 2014
Drug abraxane (maintenance) 1 2014
Drug abraxane / carboplatin 1 2017
Drug abt-869 1 2008
Drug abt-869 .25 mg 1 2007
Drug abt-869 .25 mg/kg 1 2007
Drug abt-869 0.10 mg 1 2007
Drug abt-869 0.10 mg/kg 1 2007
Drug abx 1 2013
Drug abx/with cisplatin 1 2013
Drug ac 1 2017
Drug acalabrutinib 1 2015
Radiation accelerated conformational radiotherapy 1 2001
Radiation accelerated fraction 1 2014
Drug acetaminophen 1 2019
Drug acridine carboxamide 1 1999
Diagnostic Test act-hla 1 2017
Drug active comparator (erlotinib) 1 2011
Drug acy-241 1 2015
Drug acyclovir 1 2013
Genetic ad-ccl21-dc .05 x 07 1 2018
Genetic ad-ccl21-dc 1 x 07 1 2018
Genetic ad-ccl21-dc 3 x 07 1 2018
Genetic ad-ccl21-dc exd 1 2018
Biological ad-magea3 1 2016
Biological ad100-gp96ig-hla a1 1 2007
Other adaptated physical activity 1 2019
Drug adjuvant bevacizumab 1 2005
Drug adjuvant chemotherapy (taxol 1 2009
Drug adjuvant chemotherapy (taxol/carboplatin) 1 2009
Drug adxs-503 1 2019
Drug afatinib - 1a 1 2013
Drug afatinib - 1b 1 2013
Biological aflibercept 1 2008
Drug aflibercept (ziv-aflibercept, ave0005, vegf trap, zaltrapâ®) 1 2007
Drug ag-013736 1 2008
Drug ag-013736 (axitinib) 1 2008
Radiation aggressive thoracic radiotherapy 1 2018
Drug akt inhibitor mk2206 1 2011
Drug albumin-bound paclitaxel 1 2007
Drug albumin-bound paclitaxel, carboplatin, toripalimab 1 2020
Drug albumin paclitaxel 1 2010
Drug albumin paclitaxel/carboplatin 1 2010
Drug alclometasone cream 1 2011
Drug alectnib 1 2018
Drug alflutinib mesylate (ast2818) 80mg 1 2018
Drug alflutinib mesylate (ast2818) 80mg//40 mg/ placebo 1 2018
Drug alimta injectable product 1 2019
Drug alimta/taxotere 1 2007
Drug alimtaâ® 1 2006
Device alk qpcr assay 1 2013
Drug alkotinib 1 2018
Biological allogeneic tumour lysate (melcancervac) 1 2007
Drug alt-803 / atezolizumab 1 2017
Drug alt-803 / avelumab 1 2017
Drug alt-803 / nivolumab 1 2017
Drug alt-803 / pembrolizumab 1 2017
Drug amg 102 1 2010
Drug amg 102/erlotinib 1 2010
Drug amg 386 1 2012
placebo amg 386 placebo 1 2012
Drug amg 479, everolimus, panitumumab 1 2010
Drug amg 510 1 2020
Drug amg 655 1 2007
placebo amg 655 placebo 1 2007
Drug amg 951 (rhapo2l 1 2007
Drug amg 951 (rhapo2l/trail) 1 2007
Biological amg820 1 2016
Biological amg820/pembrolizumab 1 2016
Drug amifostine 1 2004
Drug aminocamptothecin colloidal dispersion 1 1999
Drug anastrozole 1 2016
Procedure anatomical segmentectomy, lobectomy 1 2018
Procedure anatomical segmentectomy, lobectomy/bilobectomy 1 2018
Drug anlotinib hydrochloride capsule 1 2020
Drug anlotinib, oral capsule 1 2019
Drug anlotinib/icotinib 1 2018
Drug anlotinib/with osimertinib 1 2019
Drug anlotinib/with pemetrexed/carboplatin 1 2018
Biological anti-ny-eso-1 tcr transduced t cells 1 2017
Drug anti-pd-l1 monoclonal antibody mpdl3280a 1 2015
Biological anti-pd1 1 2019
Biological anti-pd1 antibody-activated tils 1 2019
Drug antibody tf2 1 2010
Other antitumor drug screening assay 1 2006
Drug ap 1 2017
Drug ap/ac 1 2017
Drug apatinib 250mg 1 2017
Drug apatinib 500mg 1 2017
Drug apatinib 750mg 1 2017
Drug apatinib mesylate tablet 1 2017
Drug apatinib mesylate tablet/with s-1 capsules 1 2017
Drug apatinib/with vinorelbine 1 2018
Drug apatinib(250mg 1 2019
Drug apatinib(250mg/d)/with egfr-tki 1 2019
Drug apg-1252 1 2019
Procedure apheresis 1 2009
Drug approved anti-pd-1 inhibitor 1 2017
Drug apricoxib/erlotinib 1 2008
Drug arm a 1 2018
Drug arm b 1 2018
Radiation arm1 (hypofractionated radiotherapy) 1 2017
Drug armodafinil 1 2011
Drug asa404 1 2008
Drug ask120067 1 2018
Drug asn007 rd 1 2018
Drug asn007: ascending doses 1 2018
Biological ast-vac2 1 2017
Drug at-101 1 2007
Drug at-101/docetaxel 1 2007
Drug at13387 1 2012
Drug atezolizumab-bevacizumab 1 2019
Drug atezolizumab (mpdl3280a), an engineered anti-programmed death-ligand 1 (anti-pd-l1) antibody 1 2015
Drug atezolizumab 1200 mg in 20 ml injection 1 2019
Biological atl001 1 2019
Drug atovaquone 1 2015
Drug atra 1 2009
Drug auranofin 1 2012
Biological autologous dendritic cell-adenovirus ccl21 vaccine 1 2008
Biological autologous dendritic cell cancer vaccine 1 2005
Drug autologous dendritic cells pulsed with antigen 1 2019
Genetic autologous genetically modified adp-a2m4cd8 cells 1 2019
Biological autologous genetically modified t cells, magea10ᶜ⁷⁹⁶t 1 2015
Biological autologous tcm cells immunotherapy 1 2018
Biological autologous wt1-tcrc4 gene-transduced cd8-positive tcm 1 2015
Biological autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes 1 2015
Biological av-299 1 2009
Biological av-299 / gefitinib 1 2009
Drug avastin in combination with paclitaxel 1 2016
Drug avastin in combination with paclitaxel/carboplatin 1 2016
Drug avastinâ® 1 2017
Drug avelumab (msb0010718c) 1 2018
Drug avelumab 1200 mg in combination with gemcitabine 1 2017
Drug avelumab 1200 mg in combination with gemcitabine/cisplatin 1 2017
Drug avelumab 1200 mg in combination with pemetrexed 1 2017
Drug avelumab 1200 mg in combination with pemetrexed/carboplatin 1 2017
Drug avelumab 800 mg in combination with gemcitabine 1 2017
Drug avelumab 800 mg in combination with gemcitabine / cisplatin. 1 2017
Drug avelumab 800 mg in combination with pemetrexed 1 2017
Drug avelumab 800 mg in combination with pemetrexed / carboplatin 1 2017
Drug avitinib maleate 1 2018
Drug axitinib (ag-013736) 1 2018
Drug azacitidine 30mg 1 2006
Drug azacitidine 30mg/m2 1 2006
Drug azacitidine 40mg 1 2006
Drug azacitidine 40mg/m2 1 2006
Drug azd2014 1 2014
Drug azd2171 1 2005
Drug azd4205 1 2018
Drug azd4785 1 2017
Drug azd6244 / erlotinib 1 2010
Drug azd8931 1 2014
Drug azd9291 40 mg 1 2015
Drug azd9291 80 mg/40 mg 1 2015
Drug azd9291 80 mg/40 mg / placebo 1 2014
Drug azd9291 tablets 1 2014
Drug b) improvement maintenance programme group, pembrolizumab 200mg, every 6 weeks, for a total of 2 years of follow-up 1 2020
Drug b) improvement maintenance programme group, pembrolizumab 200mg, every 6 weeks, for a total of 2 years of follow-up/1 year follow-up; 1 2020
Drug b: cbdca 1 2005
Drug b: cbdca/radiotherapy 1 2005
Drug b12 1 2008
Drug bavituximab/paclitaxel/carboplatin 1 2008
Drug bay 43-9006 1 2007
Drug bay 43-9006 (sorafenib) 1 2004
Drug bay59-8862 (cytotoxic taxane) 1 2002
Drug bcd-100 1 2017
Drug becatecarin 1 2000
Behavioral behavioral intervention 1 2018
Drug belinostat, carboplatin, paclitaxel 1 2011
Drug belloxa 1 2010
Drug belotaxel 1 2010
Drug belotecan 1 2009
Drug berzosertib 1 2015
Other best standard of care (bsc) 1 2005
Other best support treatment 1 2010
Other best supportive care (maintenance) 1 2014
Dietary Supplement beta-glucan 1 2008
Drug bevacizumab-eu 1 2015
Drug bevacizumab-pfizer 1 2015
Drug bevacizumab (avastin) 1 2005
Drug bevacizumab / pemetrexed 1 2009
Drug bevacizumab / pemetrexed / carboplatin 1 2009
Drug bevacizumab 15 mg 1 2010
Drug bevacizumab 15 mg/kg 1 2010
Drug bevacizumab 7.5 mg 1 2010
Drug bevacizumab 7.5 mg/kg 1 2010
Drug bevacizumab in combination with paclitaxel 1 2016
Drug bevacizumab in combination with paclitaxel/carboplatin 1 2016
Drug bevacizumab with chemotherapy, pleur-xtm catheter placement 1 2005
Drug bevacizumab, oxaliplatin, pemetrexed 1 2005
Drug bevacizumab,erlotinib 1 2008
Drug bevacizumab/erlotinib 1 2015
Drug bevacizumab/pemetrexed/cisplatin 1 2013
Drug bexarotene (targretin) 1 2005
Drug bexarotene with carboplatin 1 2002
Drug bexarotene with carboplatin/paclitaxel 1 2002
Drug bgb324 1 2016
Biological bi 1361849 1 2017
Drug bi 6727 1 2009
Drug bi 695502 1 2014
Drug bi 836845 1 2014
Drug bi 836880 1 2018
Drug bi 891065 1 2017
Drug bibf 1120 es high dose 1 2014
Drug bibf 1120 es low dose 1 2014
Drug bibf 1120 h 1 2009
Drug bibf 1120 h / docetaxel h 1 2009
Drug bibf 1120 h / docetaxel m 1 2009
Drug bibf 1120 l 1 2009
Drug bibf 1120 l / docetaxel m 1 2009
Drug bibf 1120 m 1 2009
Drug bibf 1120 m / docetaxel h 1 2009
Drug bibf 1120 m / docetaxel m 1 2009
Drug bibf 1120/docetaxel 1 2008
Drug bibw 2992 ma2 20mg 1 2008
Drug bibw 2992 ma2 20mg/day 1 2008
Drug bibw 2992 ma2 40mg 1 2008
Drug bibw 2992 ma2 40mg/day 1 2008
Drug bibw 2992 ma2 50mg 1 2008
Drug bibw 2992 ma2 50mg/day 1 2008
Drug bibw 2992 qd 1 2008
Drug bibw2992 1 2008
Drug bibw2992 / paclitaxel 1 2008
Drug biib022 with paclitaxel 1 2009
Drug biib022 with paclitaxel/carboplatin 1 2009
Procedure bilobectomy 1 2018
Drug bind-014 1 2013
Drug bind-014 (docetaxel nanoparticles for injectable suspension) 1 2014
Drug bio-11006 1 2018
Drug bio-11006/standard of care 1 2018
Drug bio 300 oral suspension 1 2015
Procedure biopsy of a metastatic lesion. 1 2013
Procedure biopsy samples 1 2005
Procedure biospecimen collection 1 2017
Drug bisphosphates 1 2008
Drug bkm120/erlotinib 1 2011
Other blood 1 2012
Diagnostic Test blood-sampled 1 2018
Biological blood-stage infection of p. vivax 1 2016
Other blood collection 1 2019
Procedure blood draw 1 2018
Procedure blood oxygen level dependent imaging 1 2019
Procedure blood sample for methylation analysis 1 2010
Other blood withdrawal 1 2016
Drug bms-813160 1 2019
Drug bms-986253 1 2019
Drug bnp7787 1 2004
Procedure bone marrow aspiration from the iliac crest 1 2015
Drug bosutinib 1 2017
Drug bpi-15086 1 2016
Drug bpi-7711 capsule 1 2017
Drug bpi-9016m 1 2016
Radiation brachytherapy 1 2005
Device breath actuated nebulizer 1 2017
Other breath collection 1 2019
Radiation breath holding 1 2006
Procedure breath test 1 2013
Device bronchoscopic thermal vapor ablation 1 2017
Drug bryostatin 1 1 2000
Drug bsc 1 2012
Drug ca 1 2018
Drug ca/nivolumab 1 2018
Drug cabazitaxel 1 2013
Drug cabazitaxel-xrp6258 (3-week cycle) 1 2011
Drug cabazitaxel-xrp6258 (5-week cycle) 1 2011
Drug cabiralizumab 1 2018
Drug cabozantinib 20 mg 1 2019
Drug cabozantinib 40 mg 1 2019
Drug cabozantinib 60 mg 1 2019
Drug calcitriol 1 2003
Drug calcitriol / docetaxel 1 2003
Drug camrelizumab/with albumin-bound paclitaxel/cisplatin 1 2020
placebo canakinumab matching placebo 1 2018
Drug canfosfamide hydrochloride 1 2002
Device capp-seq 1 2016
Biological car-t cells 1 2018
Combination Product car-t combining pd-1 knockout 1 2018
Drug carboplatin-based 1 2013
Drug carboplatin-based chemotherapy 1 2008
Drug carboplatin-nab-paclitaxel 1 2017
Drug carboplatin-paclitaxel 1 2017
Drug carboplatin-taxol-radiotherapy 1 2005
Drug carboplatin (area under the concentration curve [auc] 6) 1 2008
Drug carboplatin (auc 5) 1 2010
Drug carboplatin (auc 6) 1 2010
Drug carboplatin (dose level 1) 1 2018
Drug carboplatin (dose level 2) 1 2018
Drug carboplatin (induction) 1 2014
Drug carboplatin (palaplatin) 1 2008
Drug carboplatin ,pemetrexed 1 2018
Drug carboplatin / pemetrexed / atezolizumab 1 2019
Drug carboplatin / pemetrexed / atezolizumab / bevacizumab 1 2019
Drug carboplatin // gemcitabine // docetaxel //cisplatin 1 2007
Drug carboplatin area under the curve (auc)5 1 2016
Drug carboplatin auc 1 2019
Drug carboplatin auc 2 1 2012
Drug carboplatin auc 5 mg 1 2013
Drug carboplatin auc 5 mg/ml/min 1 2013
Drug carboplatin auc 6 1 2017
Drug carboplatin auc 6 mg 1 2013
Drug carboplatin auc 6 mg/ml/min 1 2013
Drug carboplatin auc2 1 2018
Drug carboplatin injection 1 2020
Drug carboplatin paclitaxel 1 2018
Drug carboplatin pemetrexed 1 2017
Drug carboplatin therapy 1 2008
Drug carboplatin, 5 mg 1 2008
Drug carboplatin, 6 mg 1 2008
Drug carboplatin, pemetrexed 1 2008
Drug carboplatin, pemetrexed/bevacizumab 1 2008
Drug carboplatin,pemetrexed 1 2018
Drug carboplatin/ paclitaxel 1 2018
Drug carboplatin/gemcitabine, carboplatin/taxol 1 2005
Drug carboplatin/nab paclitaxel 1 2019
Drug carboplatin/paclitaxel (cp) 1 2004
Drug carboplatin/paclitaxel/medi-575 1 2010
Drug carboplatine 1 2005
Drug carboxyamidotriazole 1 1999
Behavioral carevive cps 1 2017
Drug carotuximab (trc105) 1 2017
Drug cb-839 1 2016
Drug cbp501 1 2009
Drug cbp501 / cisplatin / pemetrexed 1 2009
Drug cc-223, erlotinib 1 2012
Drug cc-223, oral azacitidine 1 2012
Drug cc-5013 1 2005
Biological cccr-nk92 cells 1 2018
Drug ccrt arm without consolidation chemotherapy 1 2006
Drug cddp 1 2005
Drug cdp791 10mg 1 2005
Drug cdp791 10mg/kg 1 2005
Drug cdp791 20mg 1 2005
Drug cdp791 20mg/kg 1 2005
Drug cdx-1127 1 2011
Drug cediranib 1 2017
Drug cemiplimab regn2810 1 2017
Behavioral center for epidemiological studies depression scale 1 2015
Radiation centrally located lung tumor 1 2009
Drug centrum 1 2012
Drug ceritinib (ldk378) 1 2015
Drug cetuximab / cisplatin / vinorelbine 1 2005
Drug cetuximab / gefitinib 1 2005
Drug cetuximab / platinum / gemcitabine 1 2005
Drug cetuximab 250 mg 1 2009
Drug cetuximab 250 mg/m^2 1 2009
Drug cetuximab 500 mg 1 2009
Drug cetuximab 500 mg/m^2 1 2009
Drug cetuximab in combination with carboplatin 1 2009
Drug cetuximab in combination with carboplatin/gemcitabine 1 2009
Drug cetuximab/platinum-based doublet chemotherapy 1 2009
Biological cg8123 1 2004
Other chemo-irradiation 1 2004
Radiation chemoradiotherapy 1 2016
Other chemoradiotherapy regimen between pc 1 2011
Other chemoradiotherapy regimen between pc/pe 1 2011
Radiation chemoradiotherapy with integrated boost dose 1 2016
Drug chemort 1 2018
Other chemotherapy (arm a only) 1 2019
Other chemotherapy concurrent with radiotherapy 1 2019
Other chemotherapy/radiotherapy 1 2009
Procedure chemotherapy/surgery 1 2006
Procedure chest radiotherapy 1 1999
Diagnostic Test chest xray 1 2018
Drug chinese traditional medicine xh1 1 2018
Drug ci-1040 1 2002
Drug ci 1033 1 2005
Drug cilengitide 1 2009
Drug cilengitide, radiochemotherapy 1 2010
Drug cisplatin-gemzar 1 2005
Drug cisplatin-navelbine-radiotherapy 1 2005
Drug cisplatin (dose level 1) 1 2018
Drug cisplatin (dose level 2) 1 2018
Drug cisplatin (dose level 3) 1 2018
Drug cisplatin (dose level 4) 1 2018
Drug cisplatin / docetaxel 1 2008
Drug cisplatin / docetaxel / enoxaparin 1 2008
Drug cisplatin / pemetrexed 1 2009
Drug cisplatin / vinorelbine 1 2005
Drug cisplatin followed by gemcitabine 1 2007
Drug cisplatin intercalating gefitinib 1 2017
Drug cisplatin iv 1 2009
Drug cisplatin phase 1 1 2007
Drug cisplatin phase 2 1 2007
Drug cisplatin with concomitant radiotherapy 66 gy (total dose) 1 2008
Drug cisplatin) 1 2007
Drug cisplatin, dexamethasone,vitamin b12, folic acid 1 2010
Drug cisplatin, docetaxel 1 2008
Drug cisplatin, gemcitabine 1 2010
Drug cisplatin, ifosfamide, gemcitabine 1 2008
Drug cisplatin, vinorlebine, cetuximab 1 2009
Drug cisplatin. 1 2017
Drug cisplatin/ etoposide 1 2018
Drug cisplatin/carboplatin-based 1 2013
Drug cisplatin/carboplatin,pemetrexed 1 2018
Drug cisplatin/docetaxel 1 2007
Drug cisplatin/gemcitabine 1 2018
Drug cisplatin/pemetrexed 1 2015
Procedure cisplatin/radiation therapy 1 2007
Drug cisplatin/vinorelbine 1 2007
Drug cisplatin; etoposide; radiation therapy; docetaxel; neulasta 1 2008
Drug cisplatine 1 2005
Drug cisplatine, etoposide, cetuximab 1 2009
Drug cisplatinum (50mg 1 2012
Drug cisplatinum (50mg/m2) iv (in the vein) on day 1/day 8 of a 28-day cycle for 2 cycles 1 2012
Device ck 1 2009
Drug ck-101 1 2016
Drug ck-301 (cosibelimab) 1 2017
Drug cln-081 1 2019
Drug cmp-001 1 2018
Drug cofetuzumab pelidotin 1 2019
Procedure cognitive assessment 1 2016
Drug combination carboplatin 1 2004
Drug combination carboplatin/paclitaxel 1 2004
Drug combination chemotherapy (pemetrexed 1 2007
Drug combination chemotherapy (pemetrexed / cisplatin) 1 2007
Biological combination nivolumab 1 2017
Biological combination nivolumab/ipilimumab 1 2017
Drug combination of arixtra with chemotherapy 1 2007
Drug combination of nktr-214 1 2016
Drug combination of nktr-214 / nivolumab 1 2016
Drug combination of nktr-214 / nivolumab / ipilimumab 1 2016
Drug combination of sorafenib 1 2009
Drug combination of sorafenib/everolimus 1 2009
Drug combo pbf-509 (160 mg) 1 2015
Drug combo pbf-509 (160 mg) / pdr001 1 2015
Drug combo pbf-509 (320 mg) 1 2015
Drug combo pbf-509 (320 mg) / pdr001 1 2015
Drug combo pbf-509 (640 mg) 1 2015
Drug combo pbf-509 (640 mg) / pdr001 1 2015
Other communication intervention 1 2012
Radiation comparator: ct 1 2008
Radiation comparator: ct/mri/fdg-pet 1 2008
Drug comparator: erlotinib 1 2008
Drug comparator: erlotinib / dalotuzumab 1 2008
Drug comparator: erlotinib monotherapy 1 2008
Behavioral comparison group) 1 2013
Drug compound 121564 1 2018
Procedure computed tomography-guided optical sensor-guided radiofrequency ablation 1 2005
Drug concomitant docetaxel 20mg 1 2012
Radiation concomitant radiotherapy 1 2017
Drug concomitant rdt 2gy 1 2012
Other concurrent chemo-therapy 1 2010
Radiation concurrent chemoradiotherapy 1 2014
Drug concurrent chemoradiotherapy (paclitaxel 1 2008
Drug concurrent chemoradiotherapy (paclitaxel/cisplatin/radiotherapy) 1 2008
Radiation concurrent thoracic radiation therapy 1 2006
Procedure cone-beam computed tomography 1 2018
Radiation conformal radiotherapy 1 2006
Radiation conformal thoracic radiotherapy (ctrt) 1 2008
Drug consolidation chemotherapy with docetaxel 1 2006
Drug consolidation chemotherapy with docetaxel/cisplatin 1 2006
Drug consolidation sintilimab 1 2019
Drug consolidative durvalumab 1 2019
Radiation contralateral esophageal sparing technique (cest) 1 2015
Other control 1 2017
Other control / 1 2017
Drug control arm (seq): 1 2006
Radiation conventional fractionation 1 2014
Radiation conventional radiation 1 2011
Radiation conventional radiotherapy 1 2016
Radiation conventional radiotherapy (crt) 1 2013
Radiation conventionally fractionated radiotherapy (conrt) 1 2009
Other copd assessment test 1 2020
Other copd assessment test/modified medical research council dyspnea patient reported outcomes 1 2020
Device coredx pulmonary mini-forceps 1 2019
Other counseling 1 2019
Drug cp-675,206 1 2006
Drug cp-751,871 / carboplatin / paclitaxel 1 2008
Drug cpg 7909 1 2003
Drug cpi-444 1 2017
Drug cpl304110 1 2019
Drug crlx101 1 2011
Drug cross-over to osimertinib 1 2014
Procedure cryobiopsy 1 2019
Device cryosurgery 1 2016
Drug cs-1008 1 2009
Drug cs7017 tablets 1 2008
Device ct-simulation 1 2011
Device ct-simulation/4d pet-ct 1 2011
Other ct for the diagnosis 1 2016
Other ct perfusion imaging 1 2012
Diagnostic Test ct scans 1 2018
Drug ct053ptsa 1 2018
Other ctdna analysis 1 2019
Diagnostic Test ctdna blood sample 1 2019
Biological ctl 1 2019
Drug cudc-101 1 2010
Drug custirsen sodium 1 2005
Drug customized treatment 1 2008
Biological cv301 1 2016
Biological cv9201 1 2009
Biological cva21 1 2016
Biological cxcr5 modified egfr chimeric antigen receptor autologous t cells 1 2019
Radiation cyberknife stereotactic radiosurgery 1 2008
Radiation cyclical hypofractionated palliative radiation (quad shot) 1 2020
Drug cyclophosphamide/fludarabine 1 2017
Genetic cytogenetic analysis 1 2003
Drug d 1 2012
Drug d-0316 capsule 1 2019
Radiation daily hyperfractionated radiation therapy 1 2017
Radiation daily stereotactic body radiotherapy 1 2018
Drug daratumumab 1 2016
Drug dasatinib - 1a 1 2013
Drug dasatinib - 1b 1 2013
Other data feedback only 1 2012
Drug day 8 of a 28-day cycle for 2 cycles 1 2012
Biological dc vaccine 1 2016
Other dce-mri scan 1 2012
Drug debio 1143 1 2017
Behavioral decision support tool 1 2019
Drug decitabine (dac) 1 2017
Drug decitabine in combination with genistein 1 2012
Drug defactinib 1 2016
Drug defactinib (vs-6063) 1 2013
Drug demcizumab 1 2010
Biological denileukin diftitox 1 2005
Drug denosumab-nivolumab combination 1 2018
Biological depsipeptide 1 2002
Drug desloratadine 1 2015
Drug detox-b adjuvant 1 2007
Device device for pet 1 2016
Biological dex2 1 2010
Drug dexamethasone (or corticosteroid equivalent) 1 2008
Drug dexamethasone (pre- 1 2007
Drug dexamethasone (pre-/post-medication for docetaxel) 1 2007
Drug d) 1 2019
Procedure diagnostic thoracoscopy 1 1999
Other dietary fasted 1 2014
Other dietary high fat 1 2014
Behavioral dignity therapy 1 2014
Drug diphenhydramine 1 2019
Drug diprosone 1 2009
Procedure dissection of the inferior pulmonary ligament 1 2019
Drug dkn-01 1 2011
Drug dky709 1 2019
Drug dmxaa in combination with carboplatin 1 2009
Drug dmxaa in combination with carboplatin/paclitaxel 1 2009
Drug docetaxel-carboplatin 1 2009
Drug docetaxel (d) 1 2015
Drug docetaxel (taxane) 1 2005
Drug docetaxel / plinabulin (dp) 1 2015
Drug docetaxel 20mg 1 2012
Drug docetaxel 20mg/m2/week / carboplatin auc 2/weekly - concomitant chemoradiation 2gy/day 1 2012
Drug docetaxel 40mg<7m2 d1,8, 21, 28 1 2012
Drug docetaxel 40mg<7m2 d1,8, 21, 28/ gemcitabine 1200mg/m2 d1,8, 21, 28 / concomitant docetaxel 20mg/m2/w/carboplatin auc 2/w/ concomitant rdt 2gy/d 1 2012
Drug docetaxel 60 mg 1 2012
Drug docetaxel 60 mg/m2 1 2012
Drug docetaxel 75 mg/m^2 1 2016
Drug docetaxel 75 mg/m2 1 2012
Procedure docetaxel alone 1 2010
Drug docetaxel combination 1 2003
Drug docetaxel h 1 2009
Drug docetaxel m 1 2009
Drug docetaxel, bevacizumab 1 2016
Drug docetaxel, cisplatin 1 2005
Drug docetaxel/bavituximab/placebo 1 2010
Drug docetaxel/carboplatin/bevacizumab/erlotinib 1 2007
Drug docetaxel/cddp 1 2005
Drug docetaxel/cisplatin followed by gemcitabine 1 2007
Drug docetaxel/gemcitabine 1 2007
Drug docetaxel/oxaliplatin 1 2016
Drug docetaxel/reolysin 1 2012
Drug docetaxelâ® 1 2016
Drug donafenib tablets 1 2019
Biological donor-derived nk cell infusion 1 2017
Procedure dose escalation (radiotherapy treatment schedule) 1 2005
Drug dose escalation followed by treatment with mtd 1 2012
Biological dostarlimab 1 2017
Genetic dotap:chol-fus1 1 2003
Drug dovitinib 1 2012
Drug doxil 1 2015
Drug doxycline 1 2007
Drug doxycycline 1 2011
Biological drug: hyperacute lung cancer cell vaccine 1 2003
Drug ds-1062a 1 2018
Procedure dual-agent therapy 1 2010
Procedure dual-agent therapy/docetaxel alone/best supportive care 1 2010
Drug duravalumab 1 2014
Drug durvalumab (medi 4736) 1 2017
Combination Product durvalumab / danvatirsen 1 2018
Biological durvalumab /tremelimumab 1 2015
Other durvalumab/sbrt 1 2016
Drug dv281 1 2017
Drug dv281 (rp2d) 1 2017
Procedure dynamic contrast-enhanced magnetic resonance imaging 1 2008
Drug dzd9008 1 2019
Drug e7080 1 2009
Drug e7389 21 day cycle 1 2005
Drug e7389 28 day cycle 1 2005
Dietary Supplement eaa 1 2010
Dietary Supplement eaa/leu vs total aa 1 2010
Procedure ebus-tbna, eus-na 1 2017
Drug ec145 1 2012
Drug ec145 / docetaxel 1 2012
Drug ec1456 1 2013
Drug ec1456/ec20 1 2013
Drug efaproxiral 1 2000
Drug eftilagimod alpha 1 2018
Biological egf-pti 1 2018
Drug egfr-tk inhibitor 1 2018
Drug egfr-tki 1 2015
Genetic egfr mutation test 1 2009
Drug egfr/egfrviii inhibitor wsd0922-fu 1 2019
Drug egfrviii inhibitor wsd0922-fu 1 2019
Drug ekb-569 1 2003
Drug eloxatin (gemox) 1 2004
Drug emb-01 1 2018
Drug emd 273066 1 2005
Biological emd 521873 1 2009
Drug emibetuzumab 1 2013
Drug encorafenib 1 2019
Procedure endobronchial ultrasound-guided transbronchial needle aspiration (ebus-tbna) 1 2016
Procedure endobronchial ultrasound (ebus) 1 2010
Procedure endobronchial ultrasound (ebus) transbronchial needle aspirate (tbna) 1 2017
Procedure endobronchial ultrasound guided transthoracic needle biopsy 1 2006
Procedure endoscopic ultrasound staging 1 2007
Drug endostar -continued pumping into 1 2012
Drug endostar -continued pumping into/gp 1 2012
Drug endostar -injecting into 1 2012
Drug endostar -injecting into /gp 1 2012
Drug endostar(recombinant human endostatin injection) 1 2008
Drug endostatin 1 2015
Dietary Supplement energy goal-based ons 1 2018
Behavioral enhanced care (intervention group 1 2013
Behavioral enhanced care (intervention group/comparison group) 1 2013
Biological enoblituzumab/ipilimumab 1 2015
Drug enoxaparin 1 2008
Drug ensartinib with fed 1 2018
Drug ensartinib with fed/fasting 1 2018
Biological enumeration of endothelial cell progenitor in peripheral blood by flow cytometry, endothelial cell progenitor characterization by primary cell cultures 1 2009
Drug enzalutamide 1 2016
Drug enzastaurin hcl 1 2005
Drug enzyme inhibitor therapy 1 2017
Behavioral eortc qlq-c30 questionnaire 1 2020
Biological ep2101 1 2003
Drug epacadostat 100 mg 1 2016
Drug epacadostat 25 mg 1 2016
Drug epacadostat 300 mg 1 2016
Drug epirubicin 1 2005
Biological epoetin alfa 1 2002
Drug epothilone 1 2002
Drug epothilone d 1 2004
Behavioral eq-5d 1 2015
Drug erbitux 1 2010
Drug erdafitinib 1 2016
Drug eribulin 1 2011
Drug eribulin in combination 1 2013
Drug eribulin mesylate / erlotinib 1 2010
Drug erlotinib (tarceva)/bexarotene (targretin) 1 2005
Drug erlotinib / docetaxel 1 2011
Drug erlotinib / placebo 1 2007
Drug erlotinib / sorafenib 1 2007
Drug erlotinib 150 1 2014
Drug erlotinib 150/100 mg 1 2014
Drug erlotinib in combination with capecitabine 1 2009
Drug erlotinib in combination with dasatinib 1 2007
Drug erlotinib, bevacizumab 1 2010
Drug erlotinib, sunitinib 1 2007
Drug erlotinib/bevacizumab 1 2017
Drug erlotinib/bexarotene 1 2005
Drug erlotinib/placebo 1 2008
Drug erythromycin [eritex] 1 2008
Procedure escalation of dose (radiotherapy treatment) 1 2005
Radiation esophageal-sparing intensity-modulated radiotherapy 1 2016
Radiation esophageal sparing imrt 1 2009
Drug ethaselen 1 2014
Device ethicon powered vascular stapler 1 2016
Drug etirinotecan pegol (nktr-102) 1 2013
Drug etoposide (50mg 1 2012
Drug etoposide (50mg/m2) iv (in the vein) on day 1 to day 5 of a 28-day cycle for 2 cycles 1 2012
Drug etoposide (dose level 1) 1 2018
Drug etoposide (dose level 2) 1 2018
Drug etoposide 100 mg 1 2013
Drug etoposide 100 mg/m^2 1 2013
Drug eu-approved avastinâ® 1 2017
Behavioral european organization for research 1 2015
Behavioral european organization for research/treatment of cancer quality of life questionnaire c30 1 2015
Behavioral european organization for research/treatment of cancer quality of life questionnaire lc-13 1 2015
Other evaluation of response by recist 1 2017
Other evozac calming skin spray 1 2012
Drug ex vivo-expanded her2-specific t cells 1 2005
Drug exatecan mesylate 1 2000
Device exatherm-tbh system 1 2015
Other exercise / 1 2017
Behavioral exercise intervention 1 2013
Other exhaled breath collection 1 2019
Drug experimental arm (con): 1 2006
Other experimental intervention 1 2016
Drug experimental: rp2d (pbf-509 1 2015
Drug experimental: rp2d (pbf-509/pdr001)_immuno treated 1 2015
Radiation external beam radiation (dose level 1) 1 2018
Radiation external beam radiation (dose level 2) 1 2018
Radiation external beam radiation (hyperfractionated) 1 2018
Radiation external beam radiation (standard) 1 2018
Drug famitinib h 1 2015
Drug famitinib h / docetaxel 1 2015
Drug famitinib l 1 2015
Drug famitinib l / docetaxel 1 2015
Drug famitinib m 1 2015
Drug famitinib m / docetaxel 1 2015
Drug fasting 1 2018
Other fasting-mimicking diet 1 2018
Drug fate-nk100 1 2017
Procedure fatigue assessment 1 1999
Procedure fatigue assessment/management 1 1999
Device faza pet scan 1 2015
Drug fdg 1 2009
Other feces samples 1 2018
Drug fexofenadine tablet dosing 1 2016
Device fiber optic 1 2016
Biological filgrastim 1 1999
Drug filgrastim-sd 1 2002
Drug filgrastim-sd/01 1 2002
Drug first-line chemotherapy agents 1 2006
Drug fisiogel 1 2008
Other fitbit 1 2018
Drug fkb238 (bevacizumab) 1 2016
Drug flt 1 2009
Drug flt3 ligand therapy (cdx-301) 1 2016
Genetic fluorescence in situ hybridization 1 2007
Drug fluorine f 18 ara-g 1 2019
Radiation fluorine f 18 ef5 1 2009
Other fluorine f 18 fluorothymidine 1 2007
Drug fluoro-d-glucose 1 2010
Drug fluoro-l-thymidine 1 2010
Drug fluorouracil 1 2006
Drug fluoxetine 1 2000
Drug folate 1 2005
Drug folfox (oxaliplatin 1 2013
Drug folfox (oxaliplatin/leucovorin/5-fluorouracil) 1 2013
Drug follow-up for 1 year; 1 2020
Procedure forceps biopsy 1 2019
Drug fosbretabulin 1 2008
Drug fostamatinib disodium 1 2009
Procedure four dimensional computed tomographic imaging (4dct) 1 2016
Radiation fr. x 3 fractions 1 2013
Drug fr901228 1 2007
Radiation fraction 1 2018
Radiation free breathing 1 2006
Biological fresolimumab 1 2015
Combination Product fsrt 1 2020
Combination Product fsrt/with bevacizumab 1 2020
Drug fulvestrant 1 2005
Procedure functional imaging of treatment effects 1 2005
Radiation functionally adapted, dose escalated vmat radiotherapy 1 2018
Drug fusidic acid [verutex] 1 2008
Drug g-csf (pegfilgrastim) 3.6 mg 1 2013
Drug g1t38 1 2018
Drug gadolinium-dpta 1 2010
Drug galunisertib 1 2015
Drug gamma-secretase inhibitor ro4929097 1 2010
Drug ganetespib 1 2012
Biological gb222 1 2019
Drug gb226 1 2019
Drug gdc-0994 1 2015
placebo gefitinib-matching placebo 250 mg 1 2020
Drug gefitinib 250mg 1 2009
Drug gefitinib 500mg 1 2009
Drug gefitinib 500mg/gefitinib 250mg 1 2009
Drug gefitinib retreatment 1 2009
Drug gefitinib, pemetrexed,cisplatin 1 2017
Drug gefitinib/bkm120 1 2012
Drug gefitinib/docetaxel 1 2005
Drug gefitinib/metformin 1 2013
Drug gefitinib/nimotuzumab 1 2011
Drug gefitinib/olaparib 1 2011
Drug gefitinib/placebo 1 2013
Drug gemcitabine / cisplatine 1 2005
Drug gemcitabine /carboplatin 1 2011
Drug gemcitabine 1200mg 1 2012
Drug gemcitabine cisplatin followed by docetaxel 1 2007
Drug gemcitabine hcl 1 2006
Drug gemcitabine injection 1 2012
Drug gemcitabine platinum 1 2014
Drug gemcitabine platinum/with erlotinib 1 2014
Drug gemcitabine prolonged continuous infusion 1 2006
Drug gemcitabine, carboplatin 1 2005
Drug gemcitabine, carboplatin, bevacizumab 1 2006
Drug gemcitabine, cisplatin 1 2005
Drug gemcitabine/cisplatin/gemcitabine/carboplatin 1 2008
Drug gemcitabine/eloxatin (gemox) 1 2004
Drug gemcitabine/nab-paclitaxel 1 2013
Drug gemcitabine/pemetrexed, paclitaxel/gemcitabine 1 2007
Drug gemcitabine/with cisplatin 1 2013
Drug gemcitabineâ® 1 2016
Genetic genetic linkage analysis 1 2012
Drug genexol-pm 1 2013
Drug genexol-pm/gemcitabine 1 2013
Biological gi-4000 1 2008
Drug gilotrif 1 2013
Drug glesatinib 1 2016
Drug glufosfamide 1 2000
Drug gold sodium thiomalate 1 2007
Drug gp 1 2012
Drug gr-md-02 1 2015
Drug grapiprant 1 2018
Drug grapiprant/pembrolizumab 1 2018
Radiation group 1: peripherally located tumors 1 2016
Radiation group 2: peripherally located chest wall adjacent tumors 1 2016
Radiation group 3: centrally located tumors 1 2016
Biological gsk 249553 vaccine 1 2006
Drug gsk1120212 1 2011
Drug gt103 1 2020
Biological gti-2040 1 2003
Diagnostic Test guardant360 1 2018
Biological gv 1001 telomerase peptide 1 2007
Drug hbi-8000 in combination with nivolumab 1 2016
Drug hd204 1 2017
Drug hdm201 1 2016
Drug hdregn2810 1 2018
Biological hekt cell 1 2017
Drug hemay020 1 2015
Radiation heterogeneously hypofractionated radiotherapy 1 2017
Drug hh2710 1 2019
Biological high-activity natural killer 1 2016
Radiation high dose chemoradiotherapy 1 2018
Radiation high dose radiotherapy 1 2005
Other high performance liquid chromatography 1 2008
Radiation hippocampal-sparing wbrt 1 2015
Drug hki-272 1 2005
Biological hla-a*0201 1 2010
Biological hla-a0201/hla-a0206-restricted urlc10 peptides 1 2010
Biological hla-a*0201restricted urlc10 peptides with adjuvant 1 2013
Biological hla-a*0206-restricted urlc10 peptides 1 2010
Biological hla-a*2402restricted urlc10, cdca1, vegfr1 1 2009
Biological hla-a*2402restricted urlc10, cdca1, vegfr1/vegfr2 1 2009
Biological hla-a*2402restricted urlc10, cdca1,/kif20a peptides 1 2010
Biological hla-a*2402restricted urlc10, cdca1,/kif20a peptides with adjuvant 1 2013
Biological hla-a*2402restricted urlc10, ttk, vegfr1 1 2008
Biological hla-a*2402restricted urlc10, ttk, vegfr1/vegfr2 1 2008
Drug hlx04, a bevacizumab biosimilar 1 2019
Drug hlx10 1 2019
Drug hlx10, an engineered anti-pd-1 antibody 1 2019
Drug hmab biwa 4 1 2014
Drug hpph 1 2012
Biological hpv vaccine 1 2013
Drug hs-10296 1 2018
Biological hsppc-96 1 2004
Drug hycamtin, oral capsules 1 2006
Radiation hypofractionated radiation 1 2016
Radiation hypofractionated radiation/chemotherapy 1 2016
Radiation hypofractionated radiotherapy (hyport) 1 2009
Drug i124-nm404 1 2007
Drug ibi305 1 2019
Drug icotinib hydrochloride tablets 1 2019
Drug idasanutlin 1 2017
Biological idc-g305 1 2013
Drug idelalisib 1 2017
Drug ifosfamide, gemcitabine 1 2008
Dietary Supplement igen0206 1 2019
Biological ilixadencel 1 2018
Device illinois bone marrow aspiration neddle 1 2015
Drug ilx651 1 2004
Biological ima201 product 1 2017
Drug ima202 product 1 2018
Radiation image-guided adaptive radiation therapy 1 2012
Other imaging biomarker analysis 1 2007
Behavioral imaging studies) 1 2013
Biological imc-1121b (ramucirumab) 1 2010
Biological imc-a12 (cixutumumab) 1 2009
Drug imetelstat 1 2010
Drug imetelstat sodium (grn163l) 1 2007
Drug imexon 1 2006
Drug imiquimod 1 2013
Drug immu-132 1 2012
Drug immune checkpoint inhibitors 1 2016
Drug immune checkpoint inhibitors/docetaxel 1 2016
Biological immune killer cells (ikc) 1 2018
Drug immuno-therapeutic agent 1 2017
Other immunologic technique 1 2008
Biological immunotherapy 1 2016
Biological immunotherapy (standard of care) 1 2017
Drug imo-2055 1 2008
Radiation imp-288-indium 1 2010
Radiation imp-288-lutetium 1 2010
Drug imprime pgg 1 2016
Biological imprime pgg injection 1 2009
Biological imprime pggâ® injection 1 2009
Drug inbrx-106 - hexavalent ox40 agonist antibody 1 2019
Drug inc280 (capmatinib) 1 2015
Drug individualized neoantigen peptides vaccine 1 2020
Drug individualized pharmacokinetically driven paclitaxel dosing 1 2011
Drug indoximod 1 2015
Drug induction chemotherapy 1 2013
Biological infliximab 1 2002
Drug inhalation of hyperpolarized xenon gas 1 2014
Drug iniparib 1 2010
Other injection of [18f]-ods2004436 radiotracer 1 2016
Procedure injection of 99m-tc-nm-01 1 2016
Other integrated palliative care intervention 1 2009
Radiation intensity-modulated radiation therapy (imrt) 1 2017
Radiation intensity modulated radiation therapy (imrt) 1 2019
Radiation intensity modulated radiotherapy treatment 1 2013
Procedure intercostal uniportal vats 1 2017
Drug interleukin-2 (il2) 1 2017
Other internet-based intervention 1 2011
Other intervention arm 1 2013
Drug intralesional il-2 1 2017
Drug intravenous (iv) sea-cd40 1 2015
Procedure intubated anesthesia with single-lung mechanical ventilation 1 2018
Drug investigational drug 1 2002
Drug investigatorâ´s choice of chemotherapy 1 2010
Diagnostic Test invision 1 2019
Drug ipatasertib 1 2017
Drug ipi-504 1 2011
Drug ipi-549 1 2015
Drug ipi 504 1 2011
Drug ipi 504/docetaxel 1 2011
Biological ipilimumab 1 mg 1 2013
Biological ipilimumab 1 mg/kg 1 2013
Drug ipilimumab, 10 mg 1 2010
Drug ipilimumab, 3 mg 1 2010
Drug ipilimumab/radiation therapy 1 2017
Drug irx4204 1 2016
Drug isatuximab sar650984 1 2017
Drug iscar quercus 1 2006
Drug isis eif4e rx 1 2010
Drug isoquercetin 1 2014
Radiation isotoxic hypofractionated group 1 2018
Radiation isotoxic hypofractionation 1 2018
Drug isovue-200 1 2016
Drug ispinesib 1 2004
Drug itraconazole 200 mg 1 2018
Radiation itv 1 2012
Drug ixabepilone, 32 mg/m^2 1 2008
Drug ixabepilone, 32 mg/m^2 / carboplatin, 5 mg/min/ml 1 2008
Drug ixabepilone, 32 mg/m^2 / carboplatin, 6 mg/min/ml 1 2008
Drug jin fu kang 1 2005
Drug jnj-74699157 1 2019
Drug kanglaite injection 1 2019
Drug kanglaite injection/chemotherapy 1 2019
Drug karenitecin 1 2001
Drug karenitecin (bnp1350) 1 2004
Drug keytruda injectable product 1 2019
Genetic ki-67 protein expression 1 2009
Biological kif20a peptides 1 2010
Biological kif20a peptides with adjuvant 1 2013
Drug kos-1584 1 2008
Drug l-nmma 1 2017
Drug ladiratuzumab vedotin 1 2019
Procedure laser ablation 1 2018
placebo lazertinib-matching placebo 240 mg 1 2020
Drug lazertinib-matching placebo 240 mg/160 mg 1 2020
Drug lazertinib 240 mg 1 2020
Drug lazertinib 240 mg/160 mg 1 2020
Drug lbh589 1 2007
Drug lcl161 1 2016
Drug ldk378(ceritinib) 1 2017
placebo lenvatinib matched placebo 1 2012
Other less frequent surveillance strategy 1 2015
Dietary Supplement leu 1 2010
Dietary Supplement leu vs total aa 1 2010
Drug leucovorin 1 2013
Drug leucovorin calcium 1 2006
Behavioral lifestyle counseling 1 2014
Behavioral light physical activity 1 1 2018
Behavioral light physical activity 2 1 2018
Drug linagliptin 1 2017
Dietary Supplement lindera obtusiloba extract 1 2020
Drug linifanib 1 2010
Combination Product litt 1 2019
Combination Product litt / pembrolizumab 1 2019
Drug lmb-100 1 2019
Radiation local definitive radiotherapy 1 2017
Radiation local radiation therapy 1 2019
Drug lomustine 1 2006
Drug loperamide 1 2013
Genetic loss of heterozygosity analysis 1 2003
Radiation low-let cobalt-60 gamma ray therapy 1 1999
Drug loxo-292 (selpercatinib) 1 2017
Diagnostic Test lsi alk break apart dna fish test 1 2019
Drug ltt462 1 2016
Biological lucanixâ„¢ 1 2008
Procedure lung surgery 1 2015
Drug lurbinectedin (pm01183) 1 2013
Drug ly01008 1 2018
Drug ly2181308 1 2010
Drug ly293111 1 2003
Drug ly3023414 1 2014
Drug ly573636-sodium 1 2006
Drug lyc-55716 1 2018
Procedure lymphadenectomy 1 2008
Drug m2 d1,8, 21, 28 1 2012
Drug m2) iv (in the vein) on day 1 1 2012
Drug m2) iv (in the vein) on day 1 to day 5 of a 28-day cycle for 2 cycles 1 2012
Drug m200 (volociximab), carboplatin, paclitaxel 1 2008
Drug m200 (volociximab), carboplatin, paclitaxel, bevacizumab 1 2008
Drug m2es 1 2010
Drug mac-321 1 2003
Drug maintenance chemotherapy 1 2014
Procedure management 1 1999
Biological mapatumumab 1 2007
Drug marimastat 1 1999
Other mass spectrometry 1 2007
placebo matching placebo 1 2020
Drug matuzumab 1 2005
Drug mb02 (bevacizumab biosimilar drug) 1 2017
Biological mdx-1106 1 2007
Drug medi-575 1 2010
Drug medi4736 (anti-pd-l1) 1 2015
Biological medi4736 (durvalumab) 1 2015
Biological medi4736 (durvalumab)/tremelimumab 1 2015
Drug medi5752 1 2018
Drug medi7247 1 2018
Biological medi9447 1 2017
Procedure mediastinoscopy 1 2010
Other medical history data collection 1 2019
Behavioral medical outcomes study social support survey 1 2015
Drug megf0444a 1 2011
Drug mek162 1 2013
Drug merestinib 1 2016
Diagnostic Test mesothelin expression 1 2019
Other met analysis on tissue 1 2012
Other met analysis on tissue/blood 1 2012
Drug methotrexate 1 2018
Drug methoxy polyethylene glycol-epoetin beta [mircera] 1 2006
Drug metmab 1 2009
Drug metronidazole actavis 1 2008
Biological mg1-magea3 1 2016
Biological mga012 1 2015
Biological mga271 1 2011
Drug mgcd265 1 2015
Genetic microarray analysis 1 2003
Procedure microwave ablation 1 2018
Radiation mid-position radiation strategy 1 2012
Drug mifepristone/eribulin in combination 1 2013
Drug mil60 1 2017
Biological milsâ„¢ - nsclc 1 2019
Device miso pet scan 1 2015
Drug mistletoe extract 1 2007
Other mitochondria-targeted system therapy 1 2019
Other mitochondria-targeted system therapy/with radiofrequency ablation 1 2019
Drug mitomycin 1 2005
Drug mitomycin c 1 1999
Drug mk-1308 1 2018
Drug mk-3475 (phase i) 1 2015
Drug mk-3475 (phase ii) 1 2015
Biological mk-4280 1 2018
Biological mk-4830 1 2019
Biological mk-5890 1 2019
Biological mk-7684 1 2019
Drug mkc-1 1 2006
Drug mocetinostat 1 2016
Drug modafinil 1 2009
Behavioral modified medical research council 1 2015
Other modified medical research council dyspnea patient reported outcomes 1 2020
Biological modified vaccinia virus ankara vaccine expressing p53 1 2015
Device modulated electro-hyperthermia (meht) 1 2016
Biological mogamulizumab 1 2015
Procedure molecular profiling 1 2011
Drug monalizumab (iph2201 1 2019
Biological monoclonal antibody 11d10 anti-idiotype vaccine 1 2000
Biological monoclonal antibody 3h1 anti-idiotype vaccine 1 2000
Drug monotherapy (gemcitabine 1 2006
Drug monotherapy (gemcitabine/vinorelbine) 1 2006
Biological montanide isa 51 vaccine 1 2016
Drug morab-009 1 2006
Other more frequent surveillance strategy 1 2015
Drug motesanib diphosphate 1 2004
Drug motexafin gadolinium injection 1 2005
Device move for surgery preconditioning program using a wearable activity tracker (fitbit) intervention group 1 2018
Radiation mri 1 2008
Drug mtig7192a 1 2018
Radiation multiple-fraction stereotactic body radiation therapy (sbrt) 1 2009
Biological mutant p53 peptide pulsed dendritic cell vaccine 1 2001
Biological mva-muc1-il2 1 2006
Biological mycobacterium w. 1 2008
Drug n-803 1 2018
Drug n-803 / pembrolizumab 1 2018
Drug nab-paclitaxel 100 mg 1 2013
Drug nab-paclitaxel 100 mg/m^2 1 2013
Drug nab-paclitaxel iv 1 2014
Drug nab-paclitaxel/carboplatin 1 2018
Drug nadaplatin 1 2015
Drug nadaplatin/pemetrexed 1 2015
Drug nafulizumab 1 2020
Drug naloxegol 1 2017
Drug naquotinib 1 2014
Biological natural killer 1 2017
Biological natural killer t cell 1 2017
Biological natural killer/natural killer t cell 1 2017
Procedure nausea 1 1999
Procedure nausea/vomiting therapy 1 1999
Drug navarixin 1 2018
Drug navelbine 1 2005
Drug navitoclax 1 2015
Drug nb-paclitaxel 1 2019
Drug nc318 1 2018
Drug nelfinavir mesylate 1 2007
Drug neoadjuvant chemotherapy (taxol 1 2009
Drug neoadjuvant chemotherapy (taxol/carboplatin) 1 2009
Drug neoadjuvant erlotinib therapy 1 2008
Drug neoadjuvant gemcitabine 1 2008
Drug neoadjuvant gemcitabine/carboplatin therapy 1 2008
Radiation neoadjuvant stereotactic body radiation (sbrt) 1 2015
Drug neratinib 1 2013
Drug neulastaâ® (pegfilgrastim) 1 2005
Drug nexavar (sorafenib, bay43-9006) 1 2010
Drug ngr-htnf 1 2009
Drug nicotinamide 1 2015
Drug nicotine replacement therapy 1 2011
Drug nintedanib (bibf1120) 1 2008
Drug nivolumab / ipilimumab 1 2017
Drug nivolumab / plinabulin 1 2016
Drug nivolumab 360 mg 1 2017
Drug nivolumab, ipilimumab 1 2017
Drug nivolumab, pembrolizumab 1 2018
Combination Product nk cell 1 2019
Combination Product nk cell/pd-1 antibody 1 2019
Biological nk cells 1 2008
Drug nktr-214 1 2017
Diagnostic Test no daily chest xray 1 2018
Drug no local definitive radiotherapy 1 2017
Other no metformin 1 2019
Radiation no personalized dose redistribution 1 2015
Other non-active moisturizing cream 1 2008
Radiation non-daily stereotactic body radiotherapy 1 2018
Other non-investigational platinum-based doublet chemotherapy 1 2015
Radiation non-surgical lat 1 2019
Other none, standard chemotherapy only 1 2014
Drug nov-002 injection in combination with carboplatin vs. paclitaxel 1 2006
Drug nov-002 injection in combination with carboplatin vs. paclitaxel/carboplatin 1 2006
Device novottf-100m device 1 2016
Drug npi-0052 (marizomib) 1 2008
Drug npi-0052 (marizomib) / vorinostat 1 2008
Drug npi-2358 1 2008
Drug npi-2358 / docetaxel 1 2008
Drug ocz103-os 1 2013
Drug od for 12 weeks 1 2007
Drug ogx-427 1 2013
Biological olaratumab 1 2009
Drug oleclumab (medi9447) 1 2019
Drug olmutinib 1 2017
Drug omaveloxolone 1 2013
Drug ombrabulin (ave8062) 1 2010
Drug onalespib lactate 1 2015
Drug onartuzumab (metmab) 1 2011
Drug onartuzumab [metmab] 1 2014
Diagnostic Test oncomine 1 2019
Dietary Supplement oncoxinâ® 1 2018
Dietary Supplement ons from the start of radiotherapy 1 2018
Dietary Supplement ons from the time of grade 2 radiation esophagitis 1 2018
Drug opdivo 1 2017
Procedure or of all oligometastases 1 2019
Drug oral decitabine 1 2016
Drug oral taxane 1 2005
Drug oral vinorelbine/cisplatin with concomitant radiotherapy 66 gy (total dose) 1 2008
Drug ose2101 1 2016
Drug osi-774 (tarceva) 1 2005
Drug osi-774: erlotinib, tarcevatm 1 2007
Drug osimertinib 80 mg [tagrisso] 1 2017
Drug osimertinib 80mg 1 2018
Drug osimertinib 80mg/40mg 1 2018
Drug osimertininb tablet dosing 1 2016
Drug oxaliplatin, gemcitabine, bevacizumab 1 2005
Drug oxaliplatine 1 2005
Drug oxaliplatine / gemcitabine / vinorelbine 1 2005
Drug pabolizumab 1 2020
Drug paclitaxel-carboplatin 1 2008
Drug paclitaxel (cp) 1 2004
Drug paclitaxel (genexolâ®) 1 2009
Drug paclitaxel (taxane) 1 2005
Drug paclitaxel (taxol) 1 2008
Drug paclitaxel / carboplatine 1 2005
Drug paclitaxel 200mg 1 2017
Drug paclitaxel 200mg/m2 1 2017
Drug paclitaxel 45 mg 1 2018
Drug paclitaxel 45 mg/m^2 1 2018
Drug paclitaxel dosing according to smpc 1 2011
Drug paclitaxel liposome 1 2016
Drug paclitaxel loaded polymeric micelle (genexol-pmâ®) 1 2009
Drug paclitaxel micelles for injection 1 2016
Drug paclitaxel poliglumex, pemetrexed 1 2007
Drug paclitaxel, 200 mg 1 2008
Drug paclitaxel, 200 mg/m^2 1 2008
Drug paclitaxel, carboplatin 1 2008
Drug paclitaxel, carboplatin/bevacizumab,erlotinib 1 2008
Drug paclitaxel, cisplatin, carboplatin 1 2013
Drug paclitaxel, vinorelbine, cisplatin 1 2005
Drug paclitaxel/carboplatin/gefitinib 1 2010
Drug paclitaxel/cisplatin 1 2008
Drug paclitaxel/docetaxel/carboplatin/cisplatin 1 2013
Procedure pain therapy 1 1999
Drug palifermin 1 2004
Other palliative radiotherapy 1 2009
Other palliative radiotherapy/chemotherapy 1 2009
Other palliative therapy 1 2014
Procedure palliative thoracic radiotherapy 1 2005
Drug panobinostat 1 2016
Drug panobinostat (lbh589), sorafenib 1 2009
Drug panobinostat, cisplatin, pemetrexed 1 2011
Drug papaverine hydrochloride 1 2019
Drug para-toluenesulfonamide 1 2018
Procedure parametric imaging 1 2016
Drug part a - azd9291 in combination with azd6094 1 2014
Drug part a - azd9291 in combination with continuous selumetinib (asian subjects) 1 2014
Drug part a - azd9291 in combination with continuous selumetinib (non-asian subjects) 1 2014
Drug part a - azd9291 in combination with intermittent selumetinib 1 2014
Drug part a - azd9291 in combination with medi4736 1 2014
Drug part a: azd8186 monotherapy 1 2013
Drug part b - azd9291 in combination with azd6094 1 2014
Drug part b - azd9291 in combination with medi4736 1 2014
Drug part b - azd9291 in combination with selumetinib 1 2014
Drug part b: azd8186 monotherapy 1 2013
Drug part c - azd6094 monotherapy (japan only) 1 2014
Drug part c - azd9291 in combination with azd6094 (japan only) 1 2014
Drug part c1: abiraterone acetate combination with azd8186 1 2013
Drug part c2: abiraterone acetate combination with azd8186 1 2013
Drug part d - azd9291 in combination with azd6094 1 2014
Drug part d1: azd2014 combination with azd8186 1 2013
Drug part d2 azd2014 combination with azd8186 1 2013
Behavioral patient navigation 1 2016
Drug pazopanib (gw786034) 1 2008
Drug pazopanib/pemetrexed 1 2009
Drug pbf-1129 1 2017
Drug pbf-509_160 mg 1 2015
Drug pbf-509_320 mg 1 2015
Drug pbf-509_640 mg 1 2015
Drug pbf-509_80 mg 1 2015
Drug pd-0325901 1 2013
Combination Product pd-1 antibody 1 2019
Biological pd-1 knockout 1 2018
Other pd-1 knockout t cells 1 2016
Drug pd-1 mab 1 2018
Other pd-l1 positive vs pd-l1 negative nsclc patients 1 2018
Drug pd0332991 1 2011
Biological pdc*lung01 1 2019
Drug pdr001)_immuno naã¯ve 1 2015
Drug pdr001)_immuno treated 1 2015
Other pe 1 2011
Drug pegilodecakin 1 2013
Drug pegylated g-csf 1 2013
Drug pegylated irinotecan 1 2014
Drug pegylated recombinant human endostatin(peg-endo) 1 2020
Biological pembrolizumab (keytrudaâ®) 1 2019
Biological pembrolizumab 10 mg 1 2013
Biological pembrolizumab 10 mg/kg 1 2013
Drug pembrolizumab 100 mg i.v single dose 1 2016
Drug pembrolizumab 200 mg iv single dose 1 2016
Drug pembrolizumab 200 mg iv twice interval 21 days 1 2016
Drug pembrolizumab 200 mg iv twice interval 21d,surgery after 10d 1 2016
Drug pembrolizumab/bevacizumab 1 2016
Drug pembrolizumab/chemotherapy 1 2018
Drug pembrort 1 2018
Drug pemetrexed - after protocol amendment 1 2006
Drug pemetrexed - before protocol amendment 1 2006
Drug pemetrexed (alimta) in combination with gemcitabine (gemzar) 1 2002
Drug pemetrexed 1000 mg 1 2005
Drug pemetrexed 1000 mg/m2 1 2005
Drug pemetrexed 500 mg/m2 1 2005
Drug pemetrexed disodium f injection 1 2020
Drug pemetrexed phase 1 1 2007
Drug pemetrexed phase 2 1 2007
Drug pemetrexed regimen) 1 2016
Drug pemetrexed, docetaxel 1 2011
Drug pemetrexed, docetaxel/gemcitabine 1 2011
Drug pemetrexed, paclitaxel 1 2007
Drug pemetrexed/ carboplatin 1 2018
Drug pemetrexed/ cisplatin 1 2018
Drug pemetrexed/cisplatin intercalating gefitinib 1 2017
Biological pemetrexed/donor-derived nk cell infusion 1 2017
Drug pemetrexed/gemcitabine/bevacizumab 1 2007
Drug pemetrexed/reolysin (and safety run-in) 1 2012
Drug pemetrexedâ® 1 2016
Drug pentoxifylline 1 2013
Drug perifosine 1 2006
Radiation peripherally located lung tumor 1 2009
Radiation personalized dose redistribution 1 2015
Behavioral personalized exercise program 1 2017
Drug pertuzumab / trastuzumab / docetaxel 1 2019
Combination Product pet-based, dose-painted, accelerated chemoradiotherapy 1 2018
Diagnostic Test pet-mri 1 2018
Procedure pet diagnostic imaging 1 2005
Procedure pet imaging 1 2005
Diagnostic Test pet scan 1 2018
Procedure pet scan use in radiotherapy planning 1 2000
Diagnostic Test pet/ct scans 1 2018
Drug pevonedistat 1 2019
Drug pf-05082566 1 2011
Drug pf-06747775 1 2015
Drug pf-06804103 1 2017
Biological pf-06936308 1 2018
Drug pf-3512676 / erlotinib 1 2006
Procedure pharmacokinetic sampling 1 2014
Procedure pharmacokinetic sampling - rifampicin 1 2014
Procedure pharmacokinetic sampling - rosuvastatin 1 2014
Procedure pharmacokinetic sampling - simvastatin 1 2014
Radiation photons 1 2014
Procedure physical therapy 1 2019
Procedure physician does not receive the results 1 2011
Procedure physician receives qol results 1 2011
Other physiological saline 1 2012
Drug pi3k inhibitor bkm120 1 2012
Drug pictilisib 1 2011
Drug pilimumab 1 2015
Drug pirotinib 1 2018
Drug pivanex 1 2003
placebo placebo (0.9 % saline) 1 2009
placebo placebo (for bavituximab) 1 2013
placebo placebo (for ramucirumab) 1 2010
placebo placebo ast2818 80mg 1 2018
Drug placebo ast2818 80mg//40 mg 1 2018
Drug placebo azd9291 80 mg/ 40 mg 1 2014
Drug placebo azd9291 80 mg/40 mg 1 2015
placebo placebo erlotinib 1 2011
placebo placebo erlotinib 150 1 2014
Drug placebo erlotinib 150/100mg 1 2014
placebo placebo for abt-869 1 2008
placebo placebo for ipilimumab 1 2017
placebo placebo for lenvatinib 1 2019
placebo placebo for veliparib 1 2014
placebo placebo granules 1 2016
placebo placebo matching lenvatinib 1 2019
placebo placebo of aprepitant 1 2015
placebo placebo of desloratadine 1 2015
placebo placebo osimertinib 80mg 1 2018
Drug placebo osimertinib 80mg/40mg 1 2018
placebo placebo pf00299804 1 2011
placebo placebo tablet 1 2019
placebo placebo tablets 1 2008
placebo placebo to bibf 1120 es 1 2014
placebo placebo to denosumab 1 2013
placebo placebo to match zd6474, vandetanib 1 2008
placebo placebo to zoledronic acid 1 2013
Drug placebo/chemotherapy 1 2018
placebo placebo1 1 2019
placebo placebo2 1 2019
Drug platinum-based agent 1 2007
Drug platinum-based doublet chemotherapy 1 2009
Drug platinum-based two drug chemotherapy (cisplatin 1 2016
Drug platinum-based two drug chemotherapy (cisplatin/carboplatin / vinorelbine/cisplatin/carboplatin / pemetrexed regimen) 1 2016
Drug platinum / gemcitabine 1 2005
Drug platinum based chemotherapy 1 2018
Drug platinum chemotherapy (cisplatin 1 2009
Drug platinum chemotherapy (cisplatin/carboplatin) 1 2009
Drug plb1003 1 2017
Drug plinabulin 1 2016
Drug plinabulin (dp) 1 2015
Biological polyiclc 1 2012
Genetic polymorphism analysis 1 2012
Drug ponatinib 15 mg 1 2018
Drug ponatinib 30 mg 1 2018
Radiation port-first 1 2016
Radiation port-last 1 2016
Procedure positron emission tomography (pet) 1 2018
Drug post-medication for docetaxel) 1 2007
Diagnostic Test post-sabr biopsy 1 2018
Drug poziotinib once daily dosing 1 2020
Drug poziotinib once daily dosing/twice daily dosing as determined in phase 1 1 2020
Drug poziotinib twice daily dosing 1 2020
Drug pralsetinib 1 2020
Drug pralsetinib (blu-667) 1 2017
Drug pre-surgical docetaxel 1 2005
Drug pre-surgical docetaxel/cisplatin/adjuvant bevacizumab 1 2005
Drug pre-surgical treatment with bevacizumab 1 2005
Drug pre-surgical treatment with bevacizumab/chemotherapy 1 2005
Dietary Supplement prealbumin goal-based ons 1 2018
Drug premetrexed (alimta) 1 2006
Other preoperative pulmonary rehabilitation 1 2019
Radiation preoperative radiation 1 2014
Procedure preoperative radiochemotherapy 1 2005
Procedure preservation of the inferior pulmonary ligament 1 2019
Other preventive intervention 1 2016
Drug prexasertib 1 2010
Drug prinomastat 1 2000
Drug pro95780 1 2007
Drug probiotic 1 2011
Drug prolonged continuous infusion gemcitabine 1 2006
Radiation prophylactic cranial irradiation 1 2011
Genetic proteomic profiling 1 2007
Radiation proton beam radiation therapy (pbt) 1 2014
Device proton beam therapy 1 2017
Radiation proton beam therapy rt 1 2019
Drug ptk787 1 2005
Drug ptk787/ zk 222584 1 2005
Drug px-866 1 2010
Drug pyrotinib maleate 1 2018
Device q spect 1 2015
Biological qbkpn ssi 1 2014
Drug qbm076 1 2016
Behavioral qigong 1 2016
Drug ql1101 1 2017
Other qlq-c30 global health 1 2020
Other qlq-c30 global health/quality of life questionnaire 1 2020
Other quality of life questionnaire 1 2020
Other quality of life questionnaire, lung cancer-specific (qlq-lc13) 1 2020
Drug quinacrine dihydrochloride - escalation dose 1 2013
Drug quinacrine dihydrochloride - extension dose 1 2013
Drug quisinostat 1 2015
Biological racotumomab 1 2010
Procedure radiation treatment 1 2005
Radiation radiation with concurrent chemotherapy 1 2013
Radiation radical radiotherapy - definitive local treatment. 1 2019
Radiation radical radiotherapy (conventional rt 1 2015
Radiation radical radiotherapy (conventional rt/sabr) 1 2015
Radiation radiochemotherapy 1 1 2017
Radiation radiochemotherapy 2 1 2017
Radiation radiochemotherapy 3 1 2017
Radiation radiochemotherapy 4 1 2017
Radiation radiochemotherapy 5 1 2017
Radiation radiochemotherapy 6 1 2017
Radiation radiochemotherapy 7 1 2017
Procedure radiological arm 1 2005
Procedure radionuclide imaging 1 2008
Radiation radiosurgery 1 2016
Radiation radiotherapy (imrt 1 2014
Radiation radiotherapy (imrt/3-d crt) 1 2014
Radiation radiotherapy (sabr) 1 2017
Radiation radiotherapy group 1 2018
Drug radiotherapy) 1 2008
Other radiotherapy/concurrent chemo-therapy 1 2010
Drug radium-223 dichloride (xofigo, bay 88-8223) 1 2019
Drug rapamycin (drug will be held) 1 2007
Other rapid on-site evaluation 1 2013
Drug rc48 1 2020
Device real-time position transponder beacons 1 2017
Other real time registry 1 2012
Other real time registry/data feedback only 1 2012
Drug rebimastat 1 2000
Biological recombinant fowlpox-cea(6d) 1 2004
Biological recombinant fowlpox-cea(6d)/tricom vaccine 1 2004
Biological recombinant fowlpox gm-csf vaccine adjuvant 1 2004
Drug recombinant human angiostatin protein 1 2002
Biological recombinant human egf-rp64k 1 2016
Biological recombinant human egf-rp64k/montanide isa 51 vaccine 1 2016
Drug recombinant human erythropoietin (rhuepo) 1 2005
Biological recombinant human interleukin-15 1 2012
Biological recombinant interleukin-12 1 1999
Biological recombinant prame protein 1 2013
Biological recombinant prame protein/with the as15 adjuvant system gsk2302032a 1 2013
Biological recombinant vaccinia-cea(6d)-tricom vaccine 1 2004
Drug regn2810/ipi 1 2018
Drug regn5093 1 2019
Other regular diet 1 2018
Biological relatlimab 1 2016
Drug relatlimab 10 mg 1 2019
Drug relatlimab 10 mg/ml intravenous solution 1 2019
Procedure relaxation therapy 1 2019
Drug reolysin 1 2012
Drug reolysin (and safety run-in) 1 2012
Biological reolysinâ® 1 2009
Radiation response-driven adaptive radiation therapy 1 2015
Genetic reverse transcriptase-polymerase chain reaction 1 2006
Device rf ablation (rita medical systems model 1500x) 1 2008
Drug rg1507 1 2008
Drug rh-endostatin 1 2013
Drug rhenium (re 188 p2045, bay86-5284) 1 2004
Drug rhuph20 1 2018
Drug rifampicin 1 2014
Drug rifampin 1 2007
Drug rituximab 1 2011
Drug ro4929097 1 2010
Drug ro5083945 1 2010
Drug ro5490258 1 2011
Drug ro6958688 1 2017
Drug ro7198457 1 2020
Drug rofecoxib 1 2006
Drug rogaratinib 1 2018
Drug romidepsin 1 2011
Diagnostic Test ros1 ihc 1 2019
Drug rosuvastatin 1 2014
Drug rp2d (pbf-509 1 2015
Drug rp2d (pbf-509/pdr001)_immuno naã¯ve 1 2015
Drug rrx-001 1 2015
Drug rsifn-co 1 2015
Drug rucaparib 1 2019
Drug rxdx-105 1 2018
Drug s-3304 1 2004
Drug s-588410 1 2015
Drug s-8184 paclitaxel injectable emulsion 1 2002
Radiation sabr) 1 2015
Drug saf-189s 1 2020
Drug sagopilone (bay86-5302, zk 219477) 1 2005
Other saline 1 2009
Drug salirasib 1 2007
Other saliva 1 2019
Drug sapanisertib 1 2015
Drug saracatinib 1 2008
Biological sargramostim 1 2000
Drug satraplatin 1 2006
Drug satraplatin in combination with paclitaxel 1 2005
Drug sb8 1 2016
Radiation sbrt 40.0 gy 1 2008
Radiation sbrt 42.5 gy 1 2008
Radiation sbrt 45.0 gy 1 2008
Radiation sbrt 47.5 gy 1 2008
Radiation sbrt 50.0 gy 1 2008
Radiation sbrt 52.5 gy 1 2008
Radiation sbrt 55.0 gy 1 2008
Radiation sbrt 57.5 gy 1 2008
Radiation sbrt 60.0 gy 1 2008
Radiation sbrt with protons 1 2014
Radiation sbrt with protons/photons 1 2014
Radiation sbrt/tki 1 2018
Procedure scannographic arm 1 2005
Drug sch 727965 1 2008
Drug screening platform 1 2019
Drug sct-i10 1 2019
Drug sdregn2810 1 2018
Drug sdregn2810/ipi 1 2018
Drug second-line chemotherapy 1 2011
Drug second-line chemotherapy agents 1 2006
Procedure segmentectomy 1 2007
Procedure segmentectomy/wedge resection 1 2007
Drug selenium 1 2001
Drug selumetinib 75 mg 1 2012
Drug selumetinib/docetaxel 1 2014
Drug sgn-15 1 2003
Drug sgn-15, docetaxel 1 2004
Drug sgn-cd47m 1 2019
Drug sh-1028 1 2018
Drug sh t00268c 1 2005
Device sham 1 2018
Other sham control 1 2018
Drug shark cartilage extract ae-941 1 2000
Drug shenlingcao oral liquid 1 2018
Drug sid530, taxotere 1 2009
Drug sildenafil 1 2008
Drug simultaneous chemoradiotherapy for an luo 1 2019
Radiation single-fraction stereotactic body radiation therapy (sbrt) 1 2009
Drug single arm 1 2019
Drug sintilimab (approved) 1 2019
Drug sintilimab (m1b) 1 2019
Drug sintilimab/with docetaxel 1 2019
Drug sintilimab/with docetaxel monotherapy 1 2019
Drug sirolimus (rapamycin) 1 2009
Other skin biopsy 1 2013
Behavioral smoking cessation intervention 1 2017
Drug sns-595 injection 1 2005
Drug so-c101 1 2019
Drug soblidotin 1 2003
Drug sonidegib 1 2019
Drug sorafenib (nexavar) 1 2009
Drug sorafenib / docetaxel/carboplatin 1 2008
Other spect-based treatment plan 1 2012
Diagnostic Test spect-ct scan 1 2017
Procedure spectroscopy 1 2008
Procedure spontaneous ventilation 1 2018
Drug ss1 (dsfv) pe38 1 2010
Drug sta 4783 1 2004
Drug sta 9090 1 2009
Other staging of non-small cell lung carcinoma 1 2016
Combination Product standard chemoradiotherapy 1 2018
Radiation standard fractionation 1 2016
Drug standard maintenance for squamous nsclc 1 2014
Drug standard medical therapy 1 2019
Other standard palliative care group 1 2009
Drug standard platinum-based chemotherapy 1 2007
Radiation stereotactic ablative radiotherapy (sar) 1 2017
Radiation stereotactic body radiation therapy/surgery 1 2014
Radiation stereotactic body radiotherapy (sabr) 1 2015
Radiation stereotactic body radiotherapy (sbrt) 30 gy 3 fractions (#) 1 2018
Radiation stereotactic body radiotherapy (sbrt) 54 gy 3 fractions (#) 1 2018
Radiation stereotactic body radiotherapy (sbrt) dosed at the maximum tolerated dose 1 2018
Radiation stereotactic body radiotherapy/sbrt 1 2019
Radiation stereotactic radiation 1 2010
Radiation stereotactic radiation therapy (srt) 1 2017
Radiation stereotactic radiosurgery (srs) 1 2018
Radiation sterotactic body radiotherapy 1 2019
Radiation sterotactic body radiotherapy/sbrt 1 2019
Drug subcutaneous (sc) sea-cd40 1 2015
Procedure sublobar resection 1 2017
Procedure subxiphoid uniportal vats 1 2017
Drug sulijia 1 2017
Drug sunitinib/rapamycin (drug will be held) 1 2007
Behavioral support education activity 1 2018
Procedure support group therapy 1 2018
Device surgeon’s ‘standard of care’ stapler 1 2016
Procedure surgical procedure 1 1999
Procedure surgical removal of primary and 1 2019
Procedure surgical removal of primary and/or of all oligometastases 1 2019
Procedure surgical resection - definitive local treatment. 1 2019
Procedure surgical resection of tumor 1 2016
Procedure surgical staging 1 2007
Other survivorship care plan 1 2020
Drug sutent 1 2009
Drug systemic therapy 1 2019
Drug systemic therapy/standard of care 1 2019
Drug tak-573 1 2019
Drug tak-931 1 2017
Drug talazoparib 1 2019
Drug talazoparib tosylate 1 2019
Drug talcum powder 1 2019
Drug tarceva (erlotinib hcl, osi-774 ) 1 2002
Drug tarceva (erlotinib hydrochloride) 1 2009
Drug tarceva (erlotinib) 1 2006
Drug targeted molecular therapy 1 2016
Drug targomirs 1 2015
Drug tarloxotinib bromide 1 2019
Drug tas-114 1 2016
Drug taxane 1 2015
Drug taxoprexin 1 2005
Drug taxotereâ® 1 2006
Drug tc-210 t cells 1 2019
Biological tcr-t cells 1 2018
Biological tecemotide 1 2009
Radiation technetium-99 1 2004
Radiation technetium 99m ethylenedicysteine-deoxyglucose 1 2009
Radiation technetium tc-99m albumin aggregated 1 2016
Radiation technetium tc-99m sulfur colloid 1 2016
Drug telaglenastat 1 2019
Drug telaglenastat hydrochloride 1 2019
Device telecoaching 1 2019
Other telehealth 1 2020
Behavioral telephone-based intervention 1 2011
Drug telisotuzumab vedotin 1 2018
Procedure temla 1 2017
Drug temoporfin 1 2013
Biological tergenpumatucel-l 1 2015
Drug tesevatinib 1 2015
Procedure testing for mutation status 1 2010
Drug tetrahydrouridine 1 2016
Drug tetrahydrouridine (thu) 1 2017
Drug tetrathiomolybdate 1 2013
Drug tew-7197 1 2018
Drug tg01 1 2007
Procedure therapeutic bronchoscopy 1 2012
Combination Product therapeutic lymphadenectomy (temla) 1 2013
Combination Product therapeutic lymphadenectomy (temla)/stereotactic body radiation therapy (sbrt) 1 2013
Radiation thoracic irradiation / pemetrexed 1 2007
Radiation thoracic radiation 1 2017
Radiation thoracic radiation therapy 1 2019
Radiation thoracic rt 1 2019
Radiation thoracic rt/durvalumab 1 2019
Procedure thoracotomy 1 2015
Radiation three-dimensional conformal radiation therapy 1 2001
Radiation three dimensional conformal radiotherapy 1 2017
Drug thymosin 1 2018
Drug tinzaparin sodium 100 ui 1 2007
Drug tinzaparin sodium 100 ui/kg/od for 12 weeks 1 2007
Drug tiragolumab 1 2020
Drug tislelizumab carboplatin nab-paxlitaxel 1 2018
Drug tislelizumab carboplatin paxlitaxel 1 2018
Drug tislelizumab,cisplatin 1 2018
Drug tislelizumab,cisplatin/carboplatin ,pemetrexed 1 2018
Other tissue oxygen measurement 1 2014
Drug tivantinib 1 2010
Drug tivozanib (av-951) 1 2009
Drug tlk286 (telcyta) hcl for injection 1 2004
Drug tlk286 in combination with docetaxel 1 2002
Drug tlk286, cisplatin 1 2004
Biological tn lymphocytes 1 2015
Drug tno155 1 2019
Drug tocilizumab 1 2017
Procedure tomotherapy 1 2005
Drug topotecan/docetaxel combination 1 2003
Drug toripalimab injection (js001 ) combine with chemotherapy 1 2019
Drug toripalimab injection(js001 ) 1 2019
Dietary Supplement total aa vs eaa 1 2010
Dietary Supplement total aa vs eaa/leu 1 2010
Drug tpc -vinorelbine,gemcitabine,docetaxel, 1 2011
Drug tpc -vinorelbine,gemcitabine,docetaxel,/pemetrexed 1 2011
Drug tpx-0046 1 2019
Drug tq-a3334 1 2020
Drug tq-b3101 1 2019
Drug tqb2450 1 2019
Drug tqb3456 1 2018
Drug trail-r1 mab (trm-1;hgs-etr1) 1 2004
Drug trail) 1 2007
Drug trametinib 0.5 mg 1 2018
Drug trametinib 1 mg 1 2018
Drug trametinib 1.5 mg 1 2018
Drug trametinib 2 mg 1 2018
Device transcutaneous vagus nerve stimulation 1 2018
Procedure transthoracic ultrasound 1 2010
Drug trastuzumab deruxtecan 1 2017
Procedure treatment by surgical resection 1 2015
Behavioral treatment of cancer quality of life questionnaire c30 1 2015
Behavioral treatment of cancer quality of life questionnaire lc-13 1 2015
Drug treprilumab combination with platinum-containing dual-drug chemotherapy 1 2019
Biological tricom vaccine 1 2004
Diagnostic Test truesight oncology 500 1 2019
Drug ts-1 1 2013
Drug ts-1/cisplatin 1 2013
Drug tsr-022 1 2017
Drug tsr-042 1 2017
Other tumor-infiltrating lymphocyte therapy 1 2017
Procedure tumor-infiltrating lymphocytes (til) 1 2017
Other tumor collection 1 2019
Procedure tumor specimen for methylation analysis 1 2010
Drug tvb-2640 1 2018
Drug twice daily dosing as determined in phase 1 1 2020
Drug ty-9591(10mg,40mg) qd. po 1 2019
Drug u3-1287 1 2010
Drug u3-1402 1 2017
Drug ucpvax 1 2016
Drug ufur 1 2008
Drug ufur/iressa 1 2008
Procedure ultrasound-guided transbronchial needle-delivered interstitial photodynamic therapy 1 2018
Procedure ultrasound imaging 1 2008
Procedure uniportal lobectomy with complete lymphadenectomy 1 2019
Other urine collection 1 2019
Other use of [18f]fdg - pet 1 2016
Other use of [18f]fdg - pet/ct for the diagnosis/staging of non-small cell lung carcinoma 1 2016
Behavioral usual care (routine chemotherapy cycles 1 2013
Behavioral usual care (routine chemotherapy cycles/imaging studies) 1 2013
Drug utidelone injection 1 2018
Biological uv1 synthetic peptide vaccine 1 2013
Biological uv1 synthetic peptide vaccine/gm-csf 1 2013
Device v 1 2015
Device v/q spect 1 2015
Biological v934-ep 1 2008
Biological v935 1 2008
Biological v941 1 2019
Biological vaccine 1 2012
Biological vaccine / polyiclc 1 2012
Drug val401 1 2016
Drug valproic acid 1 2004
Drug vandetanib induction 1 2008
Drug vandetanib maintenance 1 2008
Drug vandetanib, selumetinib 1 2012
Drug varlilumab 3 mg 1 2019
Drug varlilumab 3 mg/kg 1 2019
Drug vatalanib 1 2008
Procedure vats 1 2015
Drug velcade/vorinostat 1 2008
Drug velcadeâ„¢ (bortezomib) for injection (formerly ps-341) 1 2003
Biological viagenpumatucel-l 1 2015
Device video-assisted thoracoscopic lobectomy with powered vascular stapler 1 2017
Procedure videothoracoscopy 1 1999
Device viewray mr-linear accelerator 1 2019
Biological vigilâ„¢ 1 2010
Drug vinblastine 1 2010
Drug vindesine 1 1999
Drug vinflunine 1 2005
Drug vinorelbine oral formulation 1 2006
Drug vinorelbine) 1 2006
Drug vinorelbine, cisplatin 1 2017
Drug vitamin a compound 1 2019
Drug volitinib 1 2015
Radiation volume modulated arc therapy 1 2014
Procedure vomiting therapy 1 1999
Biological vsv-ifnî²-nis 1 2018
Biological vv1 1 2020
Drug vx-001 1 2013
Drug vx-970 (m6620) 1 2015
Drug vx15 1 2017
Drug vx15/2503 / avelumab 1 2017
Drug w 1 2012
Drug wbrt 1 2013
Procedure wedge resection 1 2007
Drug week 1 2012
Drug weekly - concomitant chemoradiation 2gy 1 2012
Drug weekly dp chemotherapy concurrent with thoracic radiotherapy 1 2018
Diagnostic Test whole body 18f-fdg pet 1 2018
Diagnostic Test whole body 18f-fdg pet/ct 1 2018
Radiation whole brain radiation therapy 1 2012
Radiation whole brain radiation(wbi) 1 2012
Radiation whole brain radiotherapy 1 2015
Drug with albumin-bound paclitaxel 1 2020
Combination Product with bevacizumab 1 2020
Drug with cisplatin 1 2013
Drug with docetaxel 1 2019
Drug with docetaxel monotherapy 1 2019
Drug with egfr-tki 1 2019
Drug with erlotinib 1 2014
Drug with osimertinib 1 2019
Drug with pemetrexed 1 2018
Other with radiofrequency ablation 1 2019
Drug with s-1 capsules 1 2017
Biological with the as15 adjuvant system gsk2302032a 1 2013
Drug with vinorelbine 1 2018
Drug wx-0593 tablets 1 2017
Drug x-396 1 2018
Drug x-396(ensartinib) 1 2020
Drug xl147 (sar245408) 1 2008
Drug xl184 1 2008
Drug xl765 (sar245409) 1 2008
Biological xmab20717 1 2018
Biological xmabâ®22841 1 2019
Biological xmabâ®23104 1 2018
Drug xmt-1001 1 2007
Drug xmt-1522 1 2016
Biological xmt-1592 1 2020
Biological xofigo 1 2014
Drug yangyinfang 1 2016
Drug yh25448 240mg 1 2018
Drug yiqifang 1 2016
Drug yiqiyangyinfang 1 2016
Procedure yoga 1 2019
Biological young til 1 2014
Radiation yttrium y 90 anti-cea monoclonal antibody ct84.66 1 2008
Drug zactima (zd6474) 1 2007
Drug zd1839 (iressa) 1 2006
Drug zd4054 1 2008
Drug zd6474 (vandetanib) 1 2006
Drug zd6474 (vandetanib) 100mg 1 2005
Drug zd6474 (vandetanib) 200mg 1 2005
Drug zd6474 (vandetanib) 300mg 1 2005
Drug zd6474, vandetanib 1 2008
Drug zileuton 1 2003
Drug zk 222584 1 2005
Drug zn-e4 1 2018
Drug zoledronic acid 4 mg 1 2005
Drug zometa 1 2008
Radiation zr-89 labelled durvalumab pet 1 2019
Radiation zr-89 labelled durvalumab pet/ct 1 2019

Interventions over Time

Weekly studies for each intervention

Studies by Country

Country Study_Count
United States 860
China 271
NA 83
France 75
Canada 49
Japan 40
Korea, Republic of 40
United States|Canada 40
Italy 30
United Kingdom 30
Germany 28
Netherlands 28
Taiwan 21
Greece 18
Spain 15
Belgium 14
Australia 12
Denmark 10
Switzerland 9
India 7
United States|Spain 7
Israel 6
Poland 6
Singapore 6
United States|Germany 6
United States|United Kingdom 6
Russian Federation 5
United States|Puerto Rico 5
Norway 4
United States|China 4
Austria 3
Brazil 3
Sweden 3
United States|France 3
United States|India 3
United States|Korea, Republic of 3
United States|Netherlands 3
Argentina 2
China|Japan|Korea, Republic of|Taiwan 2
China|Korea, Republic of|Taiwan 2
China|Korea, Republic of|Thailand 2
Finland 2
France|Germany 2
Germany|Switzerland 2
Hong Kong 2
Hong Kong|Korea, Republic of|Singapore|Taiwan|Thailand 2
Mexico 2
Romania 2
Turkey 2
United States|Australia 2
United States|Australia|Brazil|Bulgaria|Canada|China|France|Germany|Greece|Hong Kong|Hungary|Ireland|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 2
United States|Australia|Canada 2
United States|Australia|Japan|Korea, Republic of 2
United States|Australia|Korea, Republic of|Taiwan 2
United States|Australia|Peru|Puerto Rico 2
United States|Canada|France|Germany|Italy|Spain|United Kingdom 2
United States|Canada|Germany 2
United States|Canada|Puerto Rico 2
United States|Canada|Spain|United Kingdom 2
United States|France|Hungary|Poland|Spain 2
United States|Georgia|India|Russian Federation|Ukraine 2
United States|Italy 2
United States|Japan 2
United States|Russian Federation 2
United States|Taiwan 2
NA 1
Argentina|Australia|Austria|Belgium|Brazil|China|Finland|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Russian Federation|Spain|Taiwan|Ukraine|United Kingdom 1
Argentina|Australia|Austria|Brazil|China|Colombia|Denmark|France|Germany|Greece|Hungary|India|Ireland|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Norway|Poland|Portugal|Russian Federation|Singapore|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
Argentina|Australia|Brazil|Canada|Romania|Singapore 1
Argentina|Belgium|Brazil|Bulgaria|Canada|China|Colombia|Czechia|Denmark|Germany|India|Ireland|Italy|Kazakhstan|Luxembourg|Mexico|Poland|Portugal|Romania|Slovakia|Spain|Switzerland|United Kingdom|Vietnam 1
Argentina|Brazil|Chile|Mexico 1
Argentina|Brazil|China|Colombia|Costa Rica|Denmark|Greece|Guatemala|Italy|Latvia|Lebanon|Malaysia|Mexico|Morocco|Netherlands|Panama|Peru|Philippines|Poland|Slovenia|Spain|Sweden|United Arab Emirates|United Kingdom 1
Australia|Austria|Belgium|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Latvia|Lithuania|Netherlands|New Zealand|Philippines|Poland|Portugal|Russian Federation|Singapore|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
Australia|Austria|Czechia|Greece|Hungary|Israel|Italy|Poland|Portugal|Russian Federation|Spain 1
Australia|Belarus|Brazil|Bulgaria|Chile|China|Colombia|Czechia|Georgia|Greece|Hungary|Jordan|Lebanon|Malaysia|Mexico|Philippines|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|Turkey|Ukraine 1
Australia|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|Italy|Netherlands|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
Australia|Belgium|China|France|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|Thailand 1
Australia|Belgium|China|Germany|Japan|Singapore|Spain 1
Australia|Belgium|Finland|France|Germany|Greece|India|Italy|Netherlands|Poland|Portugal|Romania|Spain|Turkey|United Kingdom 1
Australia|Belgium|France|India|Japan|Malaysia|Spain|Taiwan|Thailand 1
Australia|Belgium|France|Italy|Korea, Republic of|Lithuania|Netherlands|Poland|Romania|Singapore|Spain|Taiwan|United Kingdom 1
Australia|Belgium|Germany 1
Australia|Brazil|China|Korea, Republic of|Mexico|Taiwan 1
Australia|Brazil|Czech Republic|France|Germany|Italy|Korea, Republic of|South Africa|Taiwan|United Kingdom 1
Australia|Canada 1
Australia|China|Egypt|India|Korea, Republic of|Romania|Taiwan|Turkey 1
Australia|China|Hong Kong|Indonesia|Korea, Republic of|Philippines|Taiwan|Thailand 1
Australia|Hong Kong|Korea, Republic of|Singapore 1
Australia|Italy|Mexico|Spain 1
Australia|Netherlands|Singapore 1
Australia|New Zealand 1
Australia|New Zealand|Poland|Russian Federation|Thailand 1
Australia|New Zealand|Spain 1
Australia|Singapore 1
Australia|Taiwan 1
Australia|United Kingdom 1
Australia|United States|Austria|Belarus|Brazil|Canada|Croatia|Czechia|Denmark|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Puerto Rico|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom 1
Australia|United States|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Malaysia|Philippines|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom|Vietnam 1
Austria|Belarus|Belgium|Bulgaria|China|Croatia|Czechia|Denmark|France|Georgia|Germany|Greece|India|Israel|Italy|Korea, Republic of|Lithuania|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|Switzerland|Ukraine|United Kingdom 1
Austria|Belgium|Denmark|France|Germany|Netherlands|Norway|Switzerland|United Kingdom 1
Austria|Belgium|Denmark|Greece|Hungary|Ireland|Israel|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Ireland|Italy|Poland|Slovenia|Spain|Switzerland|United Kingdom 1
Austria|Denmark|Finland|Greece|Hungary|Ireland|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
Austria|Denmark|France|Germany|Italy|Spain 1
Austria|Germany|Greece|Italy|Netherlands|Spain 1
Austria|Germany|Hungary|Spain|Sweden 1
Bahamas|Canada 1
Bangladesh 1
Belarus|Bulgaria|Croatia|Georgia|Greece|Hungary|India|Latvia|Malaysia|Philippines|Poland|Russian Federation|Serbia|Slovakia|Thailand|Turkey|Ukraine 1
Belarus|Georgia|Germany|Hungary|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Spain|Taiwan|Thailand|Ukraine 1
Belarus|Hungary|Poland|Russian Federation|Ukraine 1
Belarus|India|Russian Federation|Ukraine 1
Belarus|Russian Federation 1
Belgium|Bosnia and Herzegovina|Bulgaria|Egypt|Estonia|Germany|Hungary|Italy|Lithuania|Poland|Romania|Saudi Arabia|Slovakia|Sweden|Taiwan 1
Belgium|Bulgaria|Estonia|France|Germany|Hong Kong|Ireland|Italy|Poland|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
Belgium|Bulgaria|France|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Norway|Poland|Portugal|Russian Federation|Slovakia|Spain|Turkey 1
Belgium|China|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Portugal|Spain|Taiwan|Thailand|United Kingdom 1
Belgium|Czech Republic|Egypt|France|Germany|Greece|Italy|Netherlands|Poland|South Africa|Spain|Switzerland 1
Belgium|Czech Republic|France|Germany|Ireland|Italy|Poland|Spain 1
Belgium|Denmark|Netherlands|Sweden|United Kingdom 1
Belgium|Estonia|Finland|France|Germany|Greece|Italy|Latvia|Lithuania|Netherlands|Norway|Poland|Spain|United Kingdom| 1
Belgium|France 1
Belgium|France|Greece|Spain 1
Belgium|France|Italy|Netherlands|United Kingdom 1
Belgium|France|Spain 1
Belgium|Germany|Luxembourg 1
Belgium|Germany|Netherlands 1
Belgium|Germany|Netherlands|Spain|Switzerland 1
Belgium|Germany|Switzerland|United Kingdom 1
Belgium|Ireland|Italy|Netherlands|Spain|Switzerland 1
Belgium|Ireland|Spain 1
Belgium|Netherlands 1
Belgium|Netherlands|United Kingdom 1
Belgium|Spain 1
Belgium|Spain|United Kingdom 1
Belgium|United States|Argentina|Brazil|Canada|China|Croatia|Denmark|Estonia|France|Germany|Hong Kong|Indonesia|Italy|Latvia|Malaysia|Mexico|Philippines|Singapore|Slovenia|Spain|Sweden|Switzerland|Thailand|Turkey 1
Belgium|United States|Australia|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Romania|Russian Federation|Spain|Taiwan|Ukraine 1
Belgium|United States|Canada|France|Italy|Poland|Spain|United Kingdom 1
Brazil|Bulgaria|China|Lithuania|Mexico|New Zealand|Poland|Russian Federation|Slovakia|Turkey 1
Brazil|Canada 1
Brazil|China|Hong Kong|India|Korea, Republic of|Taiwan|United Kingdom 1
Bulgaria 1
Bulgaria|Czech Republic|France|Romania|Ukraine 1
Canada|Argentina|Australia|Belgium|Brazil|Bulgaria|Czech Republic|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Poland|Russian Federation|Spain|Taiwan|Thailand|United Kingdom 1
Canada|Australia|Czech Republic|Netherlands|United Kingdom 1
Canada|Germany|Hong Kong|Italy|Singapore|Taiwan 1
Canada|Hungary|Poland|Romania 1
Canada|Italy 1
Canada|Korea, Republic of|Taiwan 1
Canada|United States|Australia|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
Chile|China|Croatia|Egypt|India|Malaysia|Malta|Morocco|Pakistan|Panama|Peru|South Africa|Tunisia 1
Chile|France|Italy|Korea, Republic of|Latvia|New Zealand|Poland|Spain|United Kingdom 1
China|Australia|Korea, Republic of 1
China|Denmark|Egypt|France|Germany|Netherlands|Spain|Switzerland|Turkey 1
China|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Russian Federation|Spain|Taiwan 1
China|Hong Kong|India|Korea, Republic of|Mexico|Philippines|Poland|Russian Federation|Taiwan|Turkey 1
China|Hong Kong|India|Philippines|Taiwan|Thailand|Vietnam 1
China|Hong Kong|India|Singapore|Taiwan 1
China|Hong Kong|Indonesia|Japan|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
China|Hong Kong|Indonesia|Korea, Republic of|Philippines|Taiwan|Thailand 1
China|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Spain 1
China|Hong Kong|Malaysia|Taiwan|Thailand 1
China|Hong Kong|Russian Federation|Singapore 1
China|Italy|Korea, Republic of|Malaysia|Singapore|Spain|Taiwan 1
China|Korea, Republic of 1
China|Korea, Republic of|Malaysia|Singapore|Thailand 1
China|Malaysia 1
China|Malaysia|Philippines 1
China|Thailand 1
China|United States|Argentina|Brazil|Bulgaria|Chile|Denmark|Finland|Greece|Hong Kong|India|Israel|Japan|Korea, Republic of|Malaysia|Mexico|Peru|Philippines|Poland|Portugal|Qatar|Romania|Russian Federation|Saudi Arabia|Singapore|Sweden|Turkey|Ukraine|United Kingdom 1
Cyprus 1
Czech Republic|Australia|Austria|Belgium|Canada|Chile|China|Denmark|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Lithuania|Malaysia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Ukraine|United Kingdom|Venezuela 1
Czech Republic|Germany|Netherlands 1
Czech Republic|United States|Australia|Bulgaria|Canada|France|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
Czechia|France|Germany|Greece|Italy|Poland|Romania|Spain 1
Denmark|France|Germany|Italy|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
Denmark|Germany|Italy|Spain|Sweden 1
Denmark|United Kingdom 1
Egypt 1
Egypt|Estonia|Argentina|Australia|Austria|Bosnia and Herzegovina|Brazil|Canada|China|Colombia|Czech Republic|Denmark|Ecuador|Finland|France|Germany|Hong Kong|Hungary|Iceland|Israel|Italy|Latvia|Lebanon|Lithuania|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom|Venezuela 1
Egypt|Lebanon|Saudi Arabia 1
Egypt|Malaysia|Philippines|Poland|Romania|Serbia|Thailand 1
Finland|Germany|Italy|Netherlands|United Kingdom 1
France|Germany|Greece|Italy|Korea, Republic of|Netherlands|Russian Federation|Spain|Sweden|Switzerland|Turkey|United Arab Emirates 1
France|Germany|Hungary|Poland 1
France|Germany|Italy|Netherlands|Spain|United Kingdom 1
France|Germany|Italy|Spain 1
France|Germany|Italy|Spain|United Kingdom 1
France|Germany|Spain 1
France|Italy|Spain 1
France|Jordan|Poland|Slovenia|Spain 1
France|Korea, Republic of|Spain 1
France|Korea, Republic of|Spain|United Kingdom 1
France|Switzerland|United Kingdom 1
France|United States|Australia|Austria|Belgium|Canada|Germany|Netherlands 1
France|United States|Belgium|China|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
Georgia 1
Germany|Hong Kong|United States|Australia|Canada|China|France|Hungary|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
Germany|Hungary|United States|Austria|Belgium|Canada|Czechia|France|Italy|Japan|Korea, Republic of|Philippines|Poland|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Germany|Italy 1
Germany|Italy|Netherlands|Poland|United Kingdom 1
Germany|Italy|Poland|United Kingdom 1
Germany|Netherlands|Spain|Switzerland 1
Germany|Poland 1
Germany|Spain 1
Germany|United Kingdom 1
Germany|United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Croatia|France|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Peru|Poland|Russian Federation|Serbia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
Germany|United States|Argentina|Austria|Belgium|Brazil|Denmark|France|Greece|Italy|Japan|Lebanon|Mexico|Netherlands|Oman|Slovakia|Spain|United Arab Emirates 1
Germany|United States|Argentina|Belgium|South Africa|United Kingdom 1
Germany|United States|Brazil|China|France|Greece|Hungary|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Spain|Thailand|Turkey|Ukraine|United Kingdom 1
Greece|Germany|Australia|Austria|Belgium|Canada|Czech Republic|Estonia|Finland|France|Hong Kong|Hungary|Italy|Poland|Spain 1
Hong Kong|Italy|United States|Australia|France|Germany|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
Hong Kong|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan|Thailand 1
Hong Kong|Korea, Republic of|Malaysia|Singapore|Taiwan|Thailand 1
Hong Kong|Korea, Republic of|Taiwan|Thailand 1
Hungary|Brazil|Bulgaria|Chile|Georgia|Greece|India|Lebanon|Malaysia|Mexico|Philippines|Russian Federation|Serbia|Spain|Thailand|Turkey|Ukraine 1
Hungary|Serbia|Spain 1
India|Italy|United States|Argentina|Belgium|Chile|France|Germany|Hungary|Netherlands|Norway|Poland|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
India|Japan|United States|Belgium|Hungary|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Ukraine|United Kingdom 1
Ireland 1
Ireland|Korea, Republic of|Netherlands|Singapore|Spain|Switzerland 1
Ireland|United Kingdom 1
Israel|Italy|United States|Belgium|Canada|China|France|Germany|Japan|Korea, Republic of|Netherlands|Poland|Spain|United Kingdom 1
Italy|Netherlands|Poland|South Africa|United Kingdom 1
Italy|Netherlands|Spain|United Kingdom 1
Italy|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czechia|Denmark|France|Germany|Hungary|Mexico|Netherlands|Peru|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
Japan|Korea, Republic of|Singapore|Taiwan 1
Japan|Korea, Republic of|Taiwan 1
Japan|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Chile|Colombia|Croatia|Czechia|Denmark|France|Hungary|Israel|Italy|Korea, Republic of|Mexico|Peru|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
Jordan|Lebanon 1
Kazakhstan|Russian Federation 1
Korea, Republic of|Poland 1
Malaysia|Australia|Austria|Belgium|Canada|Chile|China|Czech Republic|Denmark|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Lithuania|New Zealand|Poland|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Ukraine|United Kingdom|Venezuela 1
Mexico|Brazil|Czechia|Hungary|India|Japan|Korea, Republic of|Peru|Philippines|Poland|Russian Federation|Thailand|Turkey|Vietnam 1
Netherlands|Spain|Switzerland 1
Netherlands|United Kingdom 1
Peru|United States|Argentina|Australia|Brazil|Canada|Italy|Korea, Republic of|New Zealand|Philippines|Taiwan|Thailand 1
Poland|Albania|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Chile|China|Colombia|Croatia|Czech Republic|Ecuador|Egypt|Estonia|Finland|Germany|Greece|Guatemala|Hong Kong|Hungary|India|Indonesia|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Panama|Peru|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Slovenia|Sweden|Switzerland|Taiwan|Thailand|Turkey|Uruguay|Venezuela 1
Poland|Bulgaria|France|Greece|Hungary|Italy|Norway|Portugal|Romania|Spain|Switzerland|Turkey|United Kingdom 1
Poland|Hungary|Russian Federation 1
Poland|Romania|South Africa|Ukraine 1
Portugal 1
Russian Federation|Ukraine 1
Serbia 1
Slovakia|Spain|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Chile|Czech Republic|France|Germany|Hong Kong|Hungary|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Singapore|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Spain|Austria|Belgium|Brazil|Canada|China|Cyprus|Finland|France|Germany|Greece|Hungary|Israel|Italy|Mexico|Netherlands|Switzerland|United Kingdom 1
Spain|Belgium|France|Germany|Italy|Poland|United Kingdom 1
Spain|Switzerland|Argentina|United States|Australia|Austria|Brazil|Canada|Chile|Czechia|France|Germany|Hong Kong|Hungary|Italy|Mexico|Norway|Peru|Poland|Romania|Russian Federation|Singapore 1
Spain|United States|Australia|Belgium|France|Italy|Korea, Republic of|Taiwan|United Kingdom 1
Spain|United States|Australia|Canada|Denmark|Estonia|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Poland|Russian Federation|Switzerland|Turkey|Ukraine|United Kingdom 1
Spain|United States|Canada|Germany|Korea, Republic of|Taiwan 1
Sweden|United Kingdom 1
Taiwan|United States|Argentina|Austria|Canada|Chile|China|Denmark|France|Germany|Greece|Hungary|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Portugal|Singapore|Spain|Turkey|United Kingdom 1
Ukraine|United Kingdom|United States|Austria|Belgium|Bulgaria|Germany|Hungary|Israel|Italy|Lithuania|Romania|Slovenia 1
United Kingdom|United States|Belgium|France|Germany|Korea, Republic of|Poland|Spain|Taiwan 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|France|Germany|Hungary|Israel|Italy|Mexico|Netherlands|Peru|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|France|Germany|Israel|Italy|Japan|Latvia|Lithuania|Mexico|Netherlands|Peru|Portugal|Russian Federation|Singapore|Slovakia|Spain|Taiwan|Ukraine 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|France|Germany|Hong Kong|Hungary|Ireland|Italy|Japan|Korea, Republic of|Malaysia|Peru|Philippines|Romania|Russian Federation|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Finland|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Romania|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Denmark|Finland|France|Germany|Greece|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|France|Chile|China|Colombia|Czechia|Finland|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Peru|Poland|Romania|Russian Federation|Saudi Arabia|South Africa|Spain|Switzerland|Taiwan|Turkey|United Arab Emirates|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Chile|Colombia|Czech Republic|Egypt|Former Yugoslavia|France|Greece|Israel|Italy|Japan|Lithuania|Macedonia, The Former Yugoslav Republic of|Morocco|Norway|Philippines|Poland|Portugal|Slovenia|South Africa|Spain|Sweden|Switzerland|Tunisia 1
United States|Argentina|Australia|Austria|Belgium|Bulgaria|Chile|China|France|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Netherlands|Peru|Portugal|Romania|Russian Federation|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|China|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Philippines|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Chile|China|Czech Republic|Estonia|Finland|France|Germany|Greece|Hong Kong|Hungary|India|Italy|Korea, Republic of|Malaysia|Netherlands|Poland|Portugal|Romania|Russian Federation|Singapore|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Iceland|India|Italy|Japan|Korea, Republic of|Lebanon|Malaysia|Netherlands|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Argentina|Australia|Austria|Brazil|Canada|Colombia|France|Germany|Japan|Korea, Republic of|New Zealand|Poland|Romania|Russian Federation|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|France|Germany|Hungary|Italy|Japan|Korea, Republic of|New Zealand|Norway|Poland|Russian Federation|Spain|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Denmark|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Russian Federation|Serbia|Spain|Switzerland|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Australia|Austria|Canada|Chile|Czechia|France|Germany|Hungary|Ireland|Italy|Mexico|Netherlands|Peru|Poland|Romania|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Hong Kong|Israel|Italy|Mexico|Philippines|Romania|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Japan|Jordan|Korea, Republic of|Lebanon|Netherlands|Poland|Russian Federation|Singapore|Spain|Taiwan 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|France|Germany|Ireland|Italy|Japan|Mexico|Poland|Romania|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Costa Rica|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Panama|Peru|Poland|Russian Federation|Serbia|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|France|Germany|Greece|Ireland|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Romania|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Romania|Russian Federation|Singapore|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|Netherlands|Peru|Poland|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Ireland|Italy|Japan|Mexico|Netherlands|Poland|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|France|Germany|Greece|India|Ireland|Korea, Republic of|Netherlands|Portugal|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Colombia|France|Germany|Hong Kong|Korea, Republic of|Mexico|Philippines|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|Chile|China|France|Hungary|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Turkey 1
United States|Argentina|Australia|Belgium|Canada|China|Czechia|France|Germany|Hong Kong|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Colombia|France|Germany|Greece|Hong Kong|India|Israel|Italy|Mexico|Philippines|Portugal|South Africa|Spain|Sweden|Taiwan|United Kingdom|Venezuela 1
United States|Argentina|Australia|Bosnia and Herzegovina|Brazil|Canada|Chile|Colombia|Ecuador|Germany|Hong Kong|Hungary|Ireland|Korea, Republic of|Latvia|Macedonia, The Former Yugoslav Republic of|Malaysia|Mexico|Moldova, Republic of|Netherlands|New Zealand|Panama|Peru|Philippines|Poland|Romania|Serbia|Sweden|Taiwan|Thailand|Turkey|Ukraine 1
United States|Argentina|Australia|Brazil|Canada|Chile|China|Germany|Greece|Israel|Mexico|New Zealand|Romania|Singapore|South Africa|Sweden|Thailand 1
United States|Argentina|Australia|Brazil|Canada|Chile|Colombia|France|Germany|Hungary|Ireland|Italy|Korea, Republic of|Latvia|Mexico|Peru|Poland|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Chile|France|Germany|Hungary|Israel|Italy|Netherlands|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|China|Czechia|India|Japan|Korea, Republic of|Peru|Philippines|Russian Federation|Slovakia|South Africa|Taiwan|Thailand|United Kingdom|Vietnam 1
United States|Argentina|Australia|Brazil|Canada|China|Denmark|France|Germany|Hong Kong|India|Indonesia|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Philippines|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Brazil|Chile|Germany|Italy|United Kingdom 1
United States|Argentina|Australia|Brazil|Chile|India 1
United States|Argentina|Australia|Canada|Chile|China|France|Germany|Israel|Japan|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Australia|Canada|Czechia|Denmark|Finland|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Russian Federation|South Africa|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Australia|France|Germany|Italy|Korea, Republic of|Russian Federation|Spain|Taiwan 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|France|Germany|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Japan|Korea, Republic of|Netherlands|Pakistan|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|France|Germany|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Philippines|Romania|Russian Federation|Spain|Taiwan|Thailand|Vietnam 1
United States|Argentina|Austria|Belgium|Brazil|Canada|China|Denmark|France|Germany|Greece|India|Indonesia|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Portugal|Singapore|Spain|Thailand|Turkey|Vietnam 1
United States|Argentina|Austria|Belgium|Brazil|Canada|France|Germany|Israel|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Norway|Poland|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|China|Colombia|Czechia|France|Germany|Greece|Guatemala|Hong Kong|Hungary|Iceland|India|Israel|Italy|Japan|Jordan|Korea, Republic of|Lebanon|Malaysia|Mexico|Norway|Panama|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Argentina|Austria|Brazil|Canada|Chile|Finland|France|Germany|Greece|Guatemala|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Norway|Panama|Poland|Portugal|Russian Federation|Serbia|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Austria|Brazil|Canada|France|Germany|Greece|Hungary|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Poland|Puerto Rico|Romania|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Austria|Canada|Chile|China|Croatia|France|Germany|Greece|Hong Kong|Italy|Korea, Republic of|Mexico|Romania|Russian Federation|Spain|Sweden|Taiwan|Thailand 1
United States|Argentina|Belgium|Brazil|Canada|China|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Spain|Taiwan|Turkey|Ukraine 1
United States|Argentina|Belgium|Brazil|Canada|China|France|Germany|Ireland|Italy|Japan|Korea, Republic of|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Hong Kong|Hungary|Italy|Japan|Netherlands|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|France|Germany|Israel|Italy|Netherlands|Spain|Turkey 1
United States|Argentina|Brazil|Bulgaria|Chile|Colombia|Greece|Hungary|Mexico|Peru|Poland|Romania|Russian Federation|Spain|Turkey|Ukraine 1
United States|Argentina|Brazil|Bulgaria|Chile|Croatia|Egypt|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Thailand|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Argentina|Brazil|Canada|China|France|Greece|Hungary|Italy|Japan|Korea, Republic of|Romania|Spain|Taiwan|Turkey 1
United States|Argentina|Brazil|China|Hungary|India|Japan|Korea, Republic of|Malaysia|Peru|Russian Federation|Spain|Taiwan|Thailand|Turkey|Vietnam 1
United States|Argentina|Brazil|Czech Republic|Hungary|India 1
United States|Argentina|Canada|France|Korea, Republic of|Poland|Spain|Taiwan 1
United States|Argentina|China|Korea, Republic of 1
United States|Argentina|France|Germany|Israel|Italy|Latvia|Malaysia|Mexico|Philippines|Spain|Taiwan|United Kingdom 1
United States|Argentina|France|Germany|Israel|Italy|Latvia|Spain|United Kingdom 1
United States|Argentina|France|Hungary|Spain|Thailand 1
United States|Australia|Austria|Belarus|Bosnia and Herzegovina|China|Denmark|Egypt|France|Germany|Greece|Hungary|Israel|Italy|Japan|Kazakhstan|Korea, Republic of|Latvia|Lebanon|North Macedonia|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Singapore|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Czechia|Germany|Greece|India|Italy|Korea, Republic of|Lebanon|Malaysia|Netherlands|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Croatia|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Croatia|France|Germany|Greece|Hungary|Italy|Poland|Portugal|Romania|Russian Federation|Slovakia|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Israel|Italy|Spain 1
United States|Australia|Austria|Brazil|Bulgaria|China|Croatia|Czech Republic|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Netherlands|Poland|Romania|Spain|Taiwan|Turkey 1
United States|Australia|Austria|Brazil|China|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Serbia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Spain|Sweden|Taiwan 1
United States|Australia|Austria|Canada|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Luxembourg|Netherlands|Norway|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Canada|France|Italy|Spain|Switzerland 1
United States|Australia|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Poland|Russian Federation|Serbia|Slovenia|Spain|Ukraine 1
United States|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|France|Georgia|Germany|Hong Kong|Italy|Japan|Netherlands|Singapore|Slovenia|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Cyprus|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Netherlands|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|China|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Spain|Sweden|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
United States|Australia|Belgium|Brazil|Canada|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Russian Federation|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Chile|France|Germany|Greece|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Singapore|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Belgium|Canada|China|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Netherlands|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|China|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan 1
United States|Australia|Belgium|Canada|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Spain|Switzerland|Taiwan|Thailand|Vietnam 1
United States|Australia|Belgium|Canada|France|Germany|Ireland|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Hong Kong|Italy|Japan|Korea, Republic of|New Zealand|Norway|Russian Federation|Singapore|Spain|Sweden|Taiwan|Thailand|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|Spain 1
United States|Australia|Belgium|Canada|Greece|Spain 1
United States|Australia|Belgium|Canada|Hong Kong|Italy|Netherlands|Singapore|Spain 1
United States|Australia|Belgium|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Poland|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Croatia|Poland|Romania|Russian Federation 1
United States|Australia|Belgium|Denmark|France|Germany|Italy|Korea, Republic of|Luxembourg|Netherlands|Russian Federation|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Korea, Republic of|Poland|Spain|Sweden 1
United States|Australia|Belgium|Greece|Netherlands 1
United States|Australia|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Costa Rica|Egypt|France|Germany|Guatemala|Hong Kong|Israel|Italy|Korea, Republic of|Mexico|New Zealand|Poland|Portugal|Russian Federation|Serbia|Singapore|Spain|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Brazil|Bulgaria|Canada|China|France|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Singapore|Spain|Taiwan|Ukraine 1
United States|Australia|Brazil|Bulgaria|Chile|Croatia|Czechia|France|Germany|Greece|Hungary|India|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Philippines|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Brazil|Canada|China|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Mexico|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Brazil|Canada|Hong Kong|Korea, Republic of|Poland|Puerto Rico|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Brazil|Czech Republic|Russian Federation|Singapore 1
United States|Australia|Bulgaria 1
United States|Australia|Canada|China|Colombia|Estonia|France|Hungary|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Poland|Russian Federation|Taiwan|Turkey|Ukraine 1
United States|Australia|Canada|China|France|Italy|Japan|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Colombia|France|Hungary|Israel|Italy|Japan|Korea, Republic of|Puerto Rico|Russian Federation|Spain|United Kingdom 1
United States|Australia|Canada|Czech Republic|France|Greece|Hungary|Israel|Poland|Russian Federation|United Kingdom 1
United States|Australia|Canada|Czechia|France|Germany|Greece|Italy|Netherlands|United Kingdom 1
United States|Australia|Canada|Czechia|Hungary|Italy|Spain|United Kingdom 1
United States|Australia|Canada|Denmark|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Finland|France|Germany|Italy|Norway|Poland|Spain|Sweden 1
United States|Australia|Canada|France|Germany|Italy|Korea, Republic of|Norway|Singapore|Spain|Taiwan 1
United States|Australia|Canada|Hong Kong|Ireland|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|South Africa|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Hungary|Italy|Korea, Republic of|Poland|Taiwan|United Kingdom 1
United States|Australia|Canada|Israel|Korea, Republic of 1
United States|Australia|Chile|Croatia|France|Germany|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Ukraine 1
United States|Australia|China 1
United States|Australia|China|Hungary|Korea, Republic of|Netherlands|Poland|Russian Federation|Taiwan|Thailand|Turkey|Vietnam 1
United States|Australia|Czech Republic|France|Germany|Hungary|Poland 1
United States|Australia|France|Germany|Hungary|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Taiwan|Ukraine 1
United States|Australia|France|Germany|Italy|Japan|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Australia|France|Germany|Italy|Netherlands|Singapore|Spain|Switzerland 1
United States|Australia|France|Germany|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|France|Israel|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|France|Italy|Japan 1
United States|Australia|Germany 1
United States|Australia|Germany|Italy|United Kingdom 1
United States|Australia|Hong Kong|Korea, Republic of|Singapore|Taiwan 1
United States|Australia|Hungary|Israel|Poland|Russian Federation|United Kingdom 1
United States|Australia|Italy|Singapore|Spain 1
United States|Australia|Japan|Korea, Republic of|Spain 1
United States|Australia|New Zealand|Poland|Thailand 1
United States|Australia|Puerto Rico|South Africa 1
United States|Australia|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Italy|Netherlands|Poland|Spain|Switzerland 1
United States|Austria|Belgium|Canada|Finland|France|Germany|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
United States|Austria|Belgium|China|Denmark|Finland|France|Germany|Greece|Hungary|India|Ireland|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Korea, Republic of|Poland|Russian Federation|Taiwan|Thailand 1
United States|Austria|Canada|France|Germany|Israel|Italy|Poland|Spain 1
United States|Austria|Canada|France|Germany|Israel|Korea, Republic of 1
United States|Austria|Canada|Germany|Hungary|Ireland|Italy|Portugal 1
United States|Austria|China|Czechia|France|Georgia|Greece|Ireland|Italy|Korea, Republic of|Lithuania|Malaysia|Poland|Russian Federation|Slovakia|Thailand|Ukraine 1
United States|Austria|France|Hungary|Italy|Poland|Romania|Spain 1
United States|Austria|Germany 1
United States|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Netherlands|Poland|Russian Federation|Serbia|Slovenia|Spain|Ukraine 1
United States|Belarus|Bosnia and Herzegovina|Bulgaria|Croatia|Georgia|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Peru|Philippines|Poland|Romania|Russian Federation|Serbia|Spain|Taiwan|Thailand|Turkey|Ukraine|Vietnam 1
United States|Belgium|Brazil|Bulgaria|Canada|Czechia|France|Hungary|Italy|Mexico|Peru|Spain 1
United States|Belgium|Canada|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain 1
United States|Belgium|Canada|France|Germany|Hong Kong|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Netherlands|Portugal|Russian Federation|Singapore|Spain|Switzerland|Turkey|United Kingdom 1
United States|Belgium|Canada|France|Germany|Israel|Italy|Spain 1
United States|Belgium|Canada|France|Germany|Italy|Korea, Republic of|Poland|Spain|Sweden|Thailand|Turkey|United Kingdom 1
United States|Belgium|Canada|France|Israel|Italy|Netherlands|Spain 1
United States|Belgium|Canada|Germany|Poland|United Kingdom 1
United States|Belgium|Canada|Spain 1
United States|Belgium|China|France|Hong Kong|Japan|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Singapore|Spain|Taiwan|Thailand|Vietnam 1
United States|Belgium|China|Greece|Korea, Republic of|Portugal|Spain|Ukraine 1
United States|Belgium|Czechia|Hungary|Italy|Korea, Republic of|United Kingdom 1
United States|Belgium|Denmark|France|Hungary 1
United States|Belgium|France 1
United States|Belgium|France|Germany|Greece|Israel|Netherlands|Spain 1
United States|Belgium|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Belgium|France|Germany|Italy|Japan|Poland|Spain 1
United States|Belgium|France|Germany|Italy|Netherlands|Romania|Spain 1
United States|Belgium|France|Italy|Spain|Taiwan|Turkey 1
United States|Belgium|France|Korea, Republic of|Spain 1
United States|Belgium|France|Netherlands|United Kingdom 1
United States|Belgium|Germany|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
United States|Belgium|Germany|Italy|Poland|United Kingdom 1
United States|Belgium|Korea, Republic of|Netherlands|Taiwan|United Kingdom 1
United States|Belgium|United Kingdom 1
United States|Brazil 1
United States|Brazil|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Chile|France|Germany|Italy|Japan|Latvia|Lithuania|Mexico|Netherlands|Peru|Portugal|Russian Federation|Singapore|Slovakia|Spain|Switzerland|Taiwan|Ukraine 1
United States|Brazil|Bulgaria|Canada|China|Czech Republic|France|Hungary|Italy|Korea, Republic of|Latvia|Lithuania|Netherlands|Poland|Romania|Slovakia|South Africa|Taiwan|Thailand|Ukraine 1
United States|Brazil|Bulgaria|China|Germany|Hong Kong|Hungary|Japan|Korea, Republic of|Mexico|Peru|Poland|Russian Federation|South Africa|Taiwan|Thailand|Ukraine|United Kingdom|Vietnam 1
United States|Brazil|Bulgaria|France|Germany|Hungary|Netherlands|Poland 1
United States|Brazil|Canada|Germany|Korea, Republic of|Poland|Romania|Russian Federation|United Kingdom 1
United States|Bulgaria|Hungary|Russian Federation|Serbia 1
United States|Bulgaria|Romania 1
United States|Canada|Chile 1
United States|Canada|China|France|Hong Kong|Japan|Korea, Republic of|Singapore|Spain|Taiwan 1
United States|Canada|Czech Republic|Korea, Republic of|United Kingdom 1
United States|Canada|Denmark|France|Russian Federation 1
United States|Canada|France 1
United States|Canada|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|Romania|Spain|Taiwan|Turkey|United Kingdom 1
United States|Canada|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|United Kingdom 1
United States|Canada|France|Germany|Hungary|Japan|Poland 1
United States|Canada|France|Germany|Hungary|Spain 1
United States|Canada|France|Germany|Korea, Republic of|Netherlands|Norway|Singapore|Spain|Turkey 1
United States|Canada|France|Hong Kong|Italy|Poland|Portugal|Spain|Taiwan 1
United States|Canada|France|Italy|Portugal|Spain|Switzerland 1
United States|Canada|France|Korea, Republic of|Spain 1
United States|Canada|France|Mexico|Netherlands|Spain|Taiwan 1
United States|Canada|France|Singapore|Taiwan 1
United States|Canada|Germany|Israel|Italy|Spain 1
United States|Canada|Germany|Israel|Netherlands|Spain 1
United States|Canada|Germany|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan 1
United States|Canada|Hong Kong 1
United States|Canada|Hong Kong|Italy|Japan|Korea, Republic of|Spain|Taiwan 1
United States|Canada|Hong Kong|Korea, Republic of|Singapore|Thailand 1
United States|Canada|Hungary|India|Netherlands|Poland|Serbia|United Kingdom 1
United States|Canada|Hungary|Israel|Spain 1
United States|Canada|Hungary|Italy|Netherlands|Poland|Romania|Spain 1
United States|Canada|Hungary|Poland|Russian Federation|Slovakia 1
United States|Canada|Ireland|Peru|South Africa 1
United States|Canada|Israel 1
United States|Canada|Israel|Italy|Poland|Romania|Russian Federation|Serbia|Spain|Switzerland|Ukraine|United Kingdom 1
United States|Canada|Italy|Spain 1
United States|Canada|Japan|Korea, Republic of|Poland|Russian Federation|Taiwan|Ukraine 1
United States|Canada|Japan|Romania|South Africa 1
United States|Canada|Poland 1
United States|Canada|Poland|Portugal|Spain|United Kingdom 1
United States|Canada|Saudi Arabia 1
United States|Canada|Switzerland 1
United States|China|Germany|Italy|Japan|Korea, Republic of|Spain|Taiwan|United Kingdom 1
United States|Czech Republic|France|Poland|Spain|United Kingdom 1
United States|Czech Republic|Greece|Hungary|Netherlands|Slovakia 1
United States|Czech Republic|Hungary 1
United States|Czechia|France|Germany|Hungary|Israel|Italy|Poland|Spain|United Kingdom 1
United States|Denmark|Japan|Korea, Republic of|Netherlands|Norway|Spain|Sweden 1
United States|Denmark|Russian Federation 1
United States|Estonia|France|Germany|Japan|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Finland|France|Germany|India|Italy|South Africa|Spain|Thailand 1
United States|France|Germany|Greece|Hungary|Japan|Netherlands|Russian Federation|Spain|Taiwan|Turkey 1
United States|France|Germany|Greece|Italy|Spain 1
United States|France|Germany|India|Italy|Poland|Russian Federation|Ukraine 1
United States|France|Germany|Italy 1
United States|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Norway|Spain|Taiwan|United Kingdom 1
United States|France|Germany|Italy|Korea, Republic of|Portugal 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|France|Germany|Japan|Korea, Republic of|Malaysia|Spain|Taiwan 1
United States|France|Germany|Japan|Spain|United Kingdom 1
United States|France|Germany|Korea, Republic of|Spain|Taiwan 1
United States|France|Greece|Hungary|Italy|Korea, Republic of|Netherlands|Spain 1
United States|France|Hong Kong|Korea, Republic of|Spain|United Kingdom 1
United States|France|Israel|Japan|United Kingdom 1
United States|France|Israel|Luxembourg|Spain 1
United States|France|Israel|Spain|Taiwan 1
United States|France|Italy|Japan|Poland|Spain 1
United States|France|Italy|Korea, Republic of|Spain|Taiwan 1
United States|France|Italy|Spain 1
United States|France|Italy|Taiwan|United Kingdom 1
United States|France|Japan|Netherlands|Spain 1
United States|France|Japan|Spain 1
United States|France|Korea, Republic of|Serbia|Spain|Taiwan 1
United States|France|Korea, Republic of|Spain|Taiwan 1
United States|France|Korea, Republic of|Spain|Turkey 1
United States|France|Netherlands 1
United States|France|Netherlands|Spain 1
United States|France|Spain 1
United States|France|Spain|United Kingdom 1
United States|Germany|Argentina|Austria|Belgium|Brazil|Canada|Chile|Colombia|Czech Republic|Denmark|Greece|Hong Kong|Hungary|Italy|Korea, Republic of|Netherlands|Norway|Poland|Russian Federation|Slovakia|Spain|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Germany|Hong Kong|Japan 1
United States|Germany|Hungary|Romania 1
United States|Germany|India|Korea, Republic of 1
United States|Germany|Italy|Korea, Republic of|Poland|Spain|Switzerland 1
United States|Germany|Italy|Spain|United Kingdom 1
United States|Germany|Japan|Korea, Republic of|Puerto Rico 1
United States|Germany|Korea, Republic of|Mexico|Poland|Russian Federation 1
United States|Germany|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|Germany|Latvia|Poland|Russian Federation|Ukraine 1
United States|Germany|Puerto Rico 1
United States|Germany|Spain 1
United States|Hong Kong|Korea, Republic of|Malaysia|Singapore|Taiwan|Thailand 1
United States|Hong Kong|Korea, Republic of|Singapore|Taiwan 1
United States|Hong Kong|Netherlands|Singapore|Taiwan 1
United States|Hungary|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan 1
United States|Hungary|Korea, Republic of|Romania|Russian Federation|Taiwan 1
United States|Hungary|Poland|Russian Federation 1
United States|India|Poland|Romania 1
United States|India|United Kingdom 1
United States|Israel|Japan|Spain 1
United States|Israel|Spain 1
United States|Italy|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|France|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Italy|Japan|Poland|Romania|Russian Federation|Spain|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Italy|Korea, Republic of|Malaysia|Spain 1
United States|Italy|Korea, Republic of|Spain 1
United States|Italy|Korea, Republic of|Taiwan 1
United States|Italy|Lithuania 1
United States|Italy|Spain 1
United States|Japan|Korea, Republic of 1
United States|Japan|Korea, Republic of|Spain|Taiwan 1
United States|Japan|Spain 1
United States|Japan|Taiwan 1
United States|Korea, Republic of|Netherlands|Spain|Taiwan|United Kingdom 1
United States|Korea, Republic of|Spain|Taiwan 1
United States|Korea, Republic of|Taiwan 1
United States|Norway|United Kingdom 1
United States|Puerto Rico|South Africa 1
United States|Russian Federation|Ukraine 1
United States|South Africa 1
United States|Spain|Austria|Canada|France|Germany 1
United States|Switzerland 1

Sites per Study

Site_count Study_Count
1 919
2 164
3 86
4 80
5 79
6 32
7 55
8 38
9 34
10 36
11 31
12 34
13 30
14 17
15 24
16 28
17 18
18 10
19 21
20 22
21 18
22 11
23 11
24 15
25 13
26 10
27 8
28 6
29 6
30 16
31 9
32 10
33 11
34 4
35 7
36 5
37 8
38 10
39 3
40 5
41 3
42 10
43 4
44 10
45 3
46 4
47 8
48 3
49 1
50 5
51 4
52 7
53 2
54 2
55 2
56 4
57 3
58 2
59 5
60 6
61 1
62 2
63 2
64 3
65 5
66 2
67 2
68 2
69 7
70 3
71 4
72 3
73 3
74 3
75 2
76 1
77 1
78 3
79 3
80 2
81 1
82 1
84 5
85 3
86 3
87 3
88 2
89 1
90 2
91 3
92 3
93 3
94 4
96 1
97 2
98 1
99 1
101 4
103 1
105 2
106 1
108 1
109 1
110 3
111 1
112 1
113 2
114 2
115 1
116 2
117 2
118 2
119 2
120 1
121 1
122 1
123 4
124 3
125 1
126 1
127 1
129 1
132 1
133 5
134 1
135 1
136 1
137 1
139 1
140 1
141 4
143 2
144 1
145 2
146 1
147 2
150 1
151 1
153 1
154 4
155 2
156 1
157 4
160 1
161 1
162 1
163 1
166 1
167 3
170 1
175 1
179 1
181 1
182 3
183 1
185 1
186 1
187 1
188 2
189 2
192 2
197 1
198 1
199 1
202 1
204 1
207 1
208 1
210 1
212 1
213 2
216 1
223 1
224 3
227 1
231 2
233 1
237 1
240 2
242 1
247 2
248 1
249 1
257 1
260 1
263 1
264 2
271 1
279 1
287 1
295 2
301 1
305 1
329 1
339 1
348 1
369 2
373 1
386 1
468 1
484 1
532 1
544 1
605 1
638 1
658 1
743 1
873 1
892 1
931 1
1175 1
1498 2

Phase

Phase Study_Count
Phase 2 1012
Phase 1 426
Phase 3 359
Phase 1/Phase 2 228
N/A 179
Phase 4 43
Phase 2/Phase 3 28
Early Phase 1 16

Number of Arms

Number_of_Arms Count_of_Studies
1 944
2 797
3 150
4 80
5 23
6 19
7 10
8 5
9 8
10 5
11 2
12 1
13 1
14 2
15 1
16 1
18 2
19 1
24 1
NA 238

Number of Updates

Count of Versions Count of Studies
1 99
2 169
3 181
4 137
5 131
6 118
7 74
8 99
9 92
10 88
11 85
12 74
13 61
14 59
15 58
16 45
17 24
18 46
19 40
20 30
21 23
22 26
23 16
24 18
25 30
26 25
27 27
28 16
29 14
30 13
31 12
32 9
33 10
34 14
35 9
36 7
37 9
38 6
39 9
40 9
41 4
42 4
43 8
44 10
45 11
46 10
47 8
48 4
49 4
50 9
51 5
52 7
53 3
54 5
55 9
56 7
57 4
58 7
59 3
60 6
61 7
62 2
63 5
64 5
65 5
66 2
67 3
68 3
69 4
70 7
71 2
72 3
73 5
74 2
75 6
76 4
77 3
78 2
79 3
80 3
81 1
82 4
84 5
85 1
86 5
87 2
88 3
89 3
90 1
91 1
92 1
93 4
96 1
97 2
98 1
99 1
100 2
102 1
104 1
105 1
106 3
110 1
117 1
120 1
121 1
124 1
125 1
126 1
131 2
139 1
141 2
144 1
150 1
155 1
163 1
169 1
190 1
202 1
205 1
216 1
249 1
277 1
370 1
424 1
456 1
473 1
552 1
567 1
703 1
1518 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 44063 2192 20.101734
Contacts/Locations 24048 2004 12.000000
Recruitment Status 4180 1988 2.102616
Study Design 3770 1594 2.365119
Arms 3183 1314 2.422374
Interventions 3183 1314 2.422374
Eligibility 3142 1358 2.313697
Outcome Measures 2932 1295 2.264093
Study Identification 2887 1276 2.262539
Study Description 2402 1071 2.242764
None (earliest Version on record) 2291 2291 1.000000
Sponsor/Collaborators 1974 1087 1.816007
Oversight 1589 1120 1.418750
Conditions 1519 792 1.917929
More Information 1293 347 3.726225
References 974 520 1.873077
Results 465 465 1.000000
IPDSharing 368 301 1.222591
Baseline Characteristics 253 187 1.352941
Reported Adverse Events 192 164 1.170732
Participant Flow 173 146 1.184932
Results Submission Events 128 128 1.000000
Documents 111 99 1.121212
2020 Study Status 1 1 1.000000
Quality Control Review has not concludedReturned: February 7 1 1 1.000000

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.0 3.000 1.00000 2.0000 1.00000 40.0000 1.0000 5.0000
1st Qu. 12.0 29.000 18.00000 40.0000 40.00000 116.0000 275.7500 53.0000
Median 22.5 56.000 31.50000 70.0000 65.00000 187.0000 453.5000 107.5000
Mean 32.5 444.226 60.50474 104.0721 97.49847 634.7857 550.4119 384.6905
3rd Qu. 32.0 150.000 56.75000 122.5000 120.00000 409.7500 671.5000 195.0000
Max. 180.0 39981.000 1260.00000 970.0000 1805.00000 10000.0000 5000.0000 6586.0000

Trial Group Type

group_type Group_Count
Experimental 3076
Active Comparator 566
NA 238
Placebo Comparator 165
Other 99
No Intervention 45
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Single Group Assignment 1111
Parallel Assignment 997
NA 93
Sequential Assignment 57
Crossover Assignment 26
Factorial Assignment 7

Primary Purpose

primary_purpose Study_Count
Treatment 2120
Diagnostic 62
Supportive Care 34
Other 30
Prevention 13
Basic Science 11
NA 8
Health Services Research 6
Screening 6
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
China 59
United States 54
France 29
NA 19
Germany 12
Netherlands 11
Spain 10
Korea, Republic of 9
Japan 8
Taiwan 8
Canada 7
Italy 6
Denmark 5
United Kingdom 5
Belgium 4
Greece 4
United States|Canada 4
Mexico 3
Poland 3
Singapore 3
Austria 2
Brazil 2
Egypt 2
Ireland 2
Russian Federation 2
Argentina 1
Argentina|Chile|Colombia|Dominican Republic|India|Mexico|Peru|Taiwan|Thailand|Uruguay 1
Argentina|Chile|Colombia|Uruguay 1
Australia 1
Australia|Belgium|France|Germany|Israel|Italy|Netherlands|Norway|Switzerland|United Kingdom 1
Australia|New Zealand|Singapore 1
Austria|Belgium|Denmark|Germany|Greece|Hungary|Italy|Lithuania|Luxembourg|Netherlands|Spain|Sweden|United Kingdom 1
Austria|Belgium|Germany|Spain|Switzerland 1
Bahrain|Qatar|United Arab Emirates 1
Belgium|France|Germany|Greece|Italy|Portugal|Spain|Turkey 1
China|Japan|Korea, Republic of 1
Czechia|Germany|Poland|Spain|Switzerland|United Kingdom 1
Egypt|Lebanon|Morocco|Saudi Arabia|United Arab Emirates 1
Finland 1
Germany|Austria 1
Hong Kong|Korea, Republic of|Malaysia|Singapore 1
Hungary 1
India 1
Jordan 1
Kazakhstan 1
Korea, Republic of|Singapore 1
Norway 1
Serbia 1
Sweden 1
United States|Austria|Canada|France|Germany|Italy|Japan|Korea, Republic of|Mexico|Poland|Singapore|Spain|Taiwan 1
United States|Bolivia|Mexico|Peru|Venezuela 1
United States|Denmark 1

Sites per Study

Site_count Study_Count
1 177
2 9
3 8
4 7
5 10
6 3
7 3
8 3
9 5
10 9
11 5
12 2
13 1
14 4
15 2
17 2
18 1
21 1
22 2
23 4
24 2
25 1
26 1
28 1
29 2
31 2
32 2
33 2
35 1
37 1
39 1
41 1
42 1
43 1
44 1
46 1
50 1
56 1
61 1
63 1
71 1
72 1
73 1
81 1
88 1
92 1
101 1
111 1
118 1
133 1
145 1
152 1
170 1
198 1
299 1
405 1
432 1

Number of Updates

Count of Versions Count of Studies
1 40
2 54
3 38
4 27
5 15
6 20
7 11
8 9
9 5
10 8
11 11
12 4
13 4
14 1
15 2
16 5
17 1
19 2
20 1
21 3
22 1
23 1
25 1
26 1
27 2
28 1
32 1
34 1
37 1
40 1
44 1
47 1
49 2
50 1
54 2
55 1
56 1
60 2
63 2
64 2
66 1
67 1
68 1
69 1
70 2
78 1
82 2
83 1
84 1
131 1
500 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 3621 260 13.926923
Contacts/Locations 1528 212 7.207547
Recruitment Status 347 204 1.700980
Study Design 311 167 1.862275
None (earliest Version on record) 300 300 1.000000
Study Description 236 90 2.622222
Eligibility 159 95 1.673684
Outcome Measures 122 92 1.326087
Study Identification 110 69 1.594203
Sponsor/Collaborators 99 77 1.285714
Conditions 94 53 1.773585
Groups 94 56 1.678571
Interventions 94 56 1.678571
Oversight 67 61 1.098361
References 52 34 1.529412
IPDSharing 16 14 1.142857
Results 16 16 1.000000
More Information 8 5 1.600000
Documents 7 7 1.000000
Results Submission Events 4 4 1.000000
Baseline Characteristics 1 1 1.000000
Participant Flow 1 1 1.000000

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 70.0000
Median 160.5000
Mean 781.3209
3rd Qu 503.2500
Max 50000.0000

Observation Model

observational_model Study_Count
Cohort 188
Case-Only 66
Other 17
NA 10
Case-Control 9
Case Control 6
Case-Crossover 2
Defined Population 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 188
Retrospective 87
Cross-Sectional 14
Other 7
NA 3
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
China 7
Korea, Republic of 3
Belgium 2
Germany 2
Greece 2
Japan 2
NA 2
Denmark|Norway 1
Egypt 1
France 1
Netherlands 1
United Kingdom 1
United States 1

Sites per Study

Site_count Study_Count
1 20
2 1
5 1
8 1
34 1
44 1
73 1

Number of Updates

Count of Versions Count of Studies
1 2
2 12
3 1
4 2
5 2
6 1
8 1
9 1
10 2
18 1
41 1

Update History Change Type

Change Type Count_of_Changes Count_of_Studies ratio
Study Status 123 24 5.125000
Contacts/Locations 67 17 3.941177
None (earliest Version on record) 26 26 1.000000
Recruitment Status 22 17 1.294118
Study Design 13 11 1.181818
Sponsor/Collaborators 8 3 2.666667
Study Identification 8 6 1.333333
Eligibility 7 5 1.400000
Study Description 6 6 1.000000
Outcome Measures 5 5 1.000000
Conditions 2 2 1.000000
Groups 2 2 1.000000
Interventions 2 2 1.000000
Oversight 2 2 1.000000
IPDSharing 1 1 1.000000

Enrollment Metrics

Measure Registries
Min 20.000
1st Qu 132.000
Median 315.000
Mean 1034.808
3rd Qu 989.000
Max 7500.000

Registry Model

observational_model Study_Count
Cohort 20
Other 4
Case-Only 2

Time Perspective

time_perspective Study_Count
Prospective 21
Other 5

Follow-up

target_duration Study_Count
3 Years 11
5 Years 4
1 Year 2
24 Months 2
1 Day 1
12 Months 1
2 Years 1
20 Months 1
36 Months 1
4 Months 1
7 Years 1